false2026Q1000010488912/31xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesghc:televisionStationghc:automotiveDealershipghc:schoolsghc:countryghc:businessxbrli:pureiso4217:GBPghc:companyghc:investmentghc:claimghc:segment00001048892026-01-012026-03-310000104889us-gaap:CommonClassAMember2026-04-240000104889us-gaap:CommonClassBMember2026-04-240000104889us-gaap:ServiceMember2026-01-012026-03-310000104889us-gaap:ServiceMember2025-01-012025-03-310000104889us-gaap:ProductMember2026-01-012026-03-310000104889us-gaap:ProductMember2025-01-012025-03-3100001048892025-01-012025-03-3100001048892026-03-3100001048892025-12-3100001048892024-12-3100001048892025-03-310000104889us-gaap:CommonStockMember2025-12-310000104889us-gaap:AdditionalPaidInCapitalMember2025-12-310000104889us-gaap:RetainedEarningsMember2025-12-310000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-12-310000104889us-gaap:TreasuryStockCommonMember2025-12-310000104889us-gaap:NoncontrollingInterestMember2025-12-310000104889us-gaap:RetainedEarningsMember2026-01-012026-03-310000104889us-gaap:NoncontrollingInterestMember2026-01-012026-03-310000104889us-gaap:AdditionalPaidInCapitalMember2026-01-012026-03-310000104889us-gaap:TreasuryStockCommonMember2026-01-012026-03-310000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-01-012026-03-310000104889us-gaap:CommonStockMember2026-03-310000104889us-gaap:AdditionalPaidInCapitalMember2026-03-310000104889us-gaap:RetainedEarningsMember2026-03-310000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-03-310000104889us-gaap:TreasuryStockCommonMember2026-03-310000104889us-gaap:NoncontrollingInterestMember2026-03-310000104889us-gaap:CommonStockMember2024-12-310000104889us-gaap:AdditionalPaidInCapitalMember2024-12-310000104889us-gaap:RetainedEarningsMember2024-12-310000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310000104889us-gaap:TreasuryStockCommonMember2024-12-310000104889us-gaap:NoncontrollingInterestMember2024-12-310000104889us-gaap:RetainedEarningsMember2025-01-012025-03-310000104889us-gaap:NoncontrollingInterestMember2025-01-012025-03-310000104889us-gaap:TreasuryStockCommonMember2025-01-012025-03-310000104889us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310000104889us-gaap:CommonStockMember2025-03-310000104889us-gaap:AdditionalPaidInCapitalMember2025-03-310000104889us-gaap:RetainedEarningsMember2025-03-310000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310000104889us-gaap:TreasuryStockCommonMember2025-03-310000104889us-gaap:NoncontrollingInterestMember2025-03-310000104889ghc:TelevisionBroadcastingMember2026-03-310000104889ghc:AutomotiveMember2026-03-310000104889ghc:KaplanLanguagesGroupKLGMember2026-02-010000104889ghc:HealthcareDivisionMemberghc:OtherHealthcareMember2026-03-012026-03-3100001048892025-01-012025-12-310000104889ghc:EducationMember2025-01-012025-12-310000104889ghc:HealthcareDivisionMemberghc:OtherHealthcareMember2025-01-012025-12-310000104889ghc:ManufacturingMember2025-01-012025-12-310000104889ghc:AutomotiveMember2025-01-012025-12-310000104889ghc:EducationMemberghc:SupplementalEducationMember2025-06-012025-06-300000104889ghc:ArconicArchitecturalProductsLLCMemberghc:HooverTreatedWoodProductsMemberghc:ManufacturingMember2025-07-310000104889ghc:HealthcareDivisionMemberghc:OtherHealthcareMember2025-10-012025-10-310000104889ghc:HondaAutoDealershipMemberghc:AutomotiveMember2025-10-310000104889ghc:HondaAutoDealershipMemberus-gaap:DelayedDrawTermLoanMemberghc:AutomotiveMember2025-10-310000104889us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember2025-12-310000104889us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMemberghc:KaplanLanguagesGroupKLGMember2026-03-310000104889ghc:KaplanLanguagesGroupKLGMember2026-01-012026-03-310000104889ghc:KaplanLanguagesGroupKLGMember2026-03-310000104889ghc:CSIPharmacyHoldingCompanyLLCMember2026-03-012026-03-310000104889ghc:CSIPharmacyHoldingCompanyLLCMemberghc:CashPaidForCSIMinoritySharesMember2026-03-012026-03-310000104889ghc:CSIPharmacyHoldingCompanyLLCMemberghc:PromissoryNotesForCSIMinoritySharesDue2028Member2026-03-012026-03-310000104889ghc:CSIPharmacyHoldingCompanyLLCMemberghc:PromissoryNotesForCSIMinoritySharesDue2028Member2026-03-310000104889ghc:GrahamHoldingsCompanyMemberghc:CSIPharmacyHoldingCompanyLLCMember2026-03-310000104889ghc:ClarusMember2026-01-012026-01-310000104889ghc:GrahamHoldingsCompanyMemberghc:ClarusMember2026-03-310000104889ghc:ClarusMember2025-10-012025-10-310000104889ghc:GrahamHoldingsCompanyMemberghc:ClarusMember2025-10-310000104889ghc:CSIPharmacyHoldingCompanyLLCMember2025-07-012025-07-310000104889ghc:GHCOneMember2025-02-250000104889ghc:GHCOneMemberghc:CashPaidToSettleASignificantPortionOfTheMandatorilyRedeemableNoncontrollingInterestMember2025-02-250000104889ghc:GHCOneMemberghc:GHCClassBCommonStockIssuedMember2025-02-250000104889ghc:GHCOneMemberus-gaap:SecuritiesSubjectToMandatoryRedemptionMember2025-02-252025-02-250000104889ghc:RemainingGHCOneAndGHCTwoMember2026-03-310000104889ghc:GHCOneMember2026-03-310000104889ghc:CSIPharmacyHoldingCompanyLLCMember2024-12-012024-12-310000104889ghc:CSIPharmacyHoldingCompanyLLCMemberghc:CashPaidForCSIMinoritySharesMember2024-12-012024-12-310000104889ghc:CSIPharmacyHoldingCompanyLLCMemberghc:PromissoryNoteForCSIMinoritySharesDue2026Member2024-12-012024-12-310000104889ghc:CSIPharmacyHoldingCompanyLLCMemberghc:PromissoryNoteForCSIMinoritySharesDue2026Member2024-12-310000104889ghc:GrahamHoldingsCompanyMemberghc:CSIPharmacyHoldingCompanyLLCMember2024-12-310000104889ghc:CSIPharmacyHoldingCompanyLLCMemberghc:AdditionalAmountPayableForCSIMinoritySharesMember2025-12-012025-12-310000104889ghc:CSIPharmacyHoldingCompanyLLCMemberghc:AdditionalAmountPayableForCSIMinoritySharesMember2025-12-310000104889ghc:MarkelGroupIncMember2025-12-310000104889ghc:MarkelGroupIncMember2026-03-310000104889ghc:BerkshireHathawayMemberus-gaap:CommonClassAMember2026-03-310000104889ghc:BerkshireHathawayMemberus-gaap:CommonClassBMember2026-03-310000104889ghc:BerkshireHathawayMember2026-03-310000104889ghc:ConcentrationInSingleMarketableEquitySecurityMemberus-gaap:AssetsTotalMember2026-01-012026-03-310000104889ghc:ResidentialHomeHealthIllinoisMemberghc:HealthcareDivisionMember2026-03-310000104889ghc:MaryFreeBedAtHomeMemberghc:HealthcareDivisionMember2026-03-310000104889ghc:AlleghenyHealthNetworkHealthcareAtHomeMemberghc:HealthcareDivisionMember2026-03-310000104889ghc:ResidentialHospiceIllinoisMemberghc:HealthcareDivisionMember2026-03-310000104889ghc:HealthcareDivisionMemberus-gaap:RelatedPartyMember2026-01-012026-03-310000104889ghc:HealthcareDivisionMemberus-gaap:RelatedPartyMember2025-01-012025-03-310000104889ghc:N2KNetworksMember2026-03-310000104889ghc:RealmMember2026-03-310000104889ghc:IntersectionMember2026-03-310000104889ghc:N2KNetworksMember2024-05-012024-05-310000104889ghc:YorkJointVentureMemberghc:KIHLMember2026-03-310000104889ghc:YorkJointVentureMemberghc:KIHLMember2026-01-012026-03-310000104889ghc:VehicleFloorPlanFacilityMemberghc:AutomotiveMember2026-01-012026-03-310000104889ghc:VehicleFloorPlanFacilityMemberghc:AutomotiveMember2025-01-012025-03-310000104889ghc:AutomotiveMember2026-01-012026-03-310000104889ghc:AutomotiveMember2025-01-012025-03-310000104889ghc:VehicleFloorPlanFacilityNewVehiclesMemberghc:AutomotiveMember2026-03-310000104889ghc:VehicleFloorPlanFacilityNewVehiclesMemberghc:AutomotiveMember2025-12-310000104889ghc:EducationMemberghc:KaplanInternationalMember2026-01-012026-03-310000104889ghc:EducationMember2025-12-310000104889ghc:TelevisionBroadcastingMember2025-12-310000104889ghc:HealthcareDivisionMember2025-12-310000104889ghc:ManufacturingMember2025-12-310000104889ghc:AutomotiveMember2025-12-310000104889us-gaap:AllOtherSegmentsMember2025-12-310000104889ghc:EducationMember2026-01-012026-03-310000104889ghc:TelevisionBroadcastingMember2026-01-012026-03-310000104889ghc:HealthcareDivisionMember2026-01-012026-03-310000104889ghc:ManufacturingMember2026-01-012026-03-310000104889us-gaap:AllOtherSegmentsMember2026-01-012026-03-310000104889ghc:EducationMember2026-03-310000104889ghc:HealthcareDivisionMember2026-03-310000104889ghc:ManufacturingMember2026-03-310000104889us-gaap:AllOtherSegmentsMember2026-03-310000104889ghc:EducationAndHealthcareDivisionsMember2026-01-012026-03-310000104889ghc:EducationMemberghc:KaplanInternationalMember2025-12-310000104889ghc:EducationMemberghc:HigherEducationMember2025-12-310000104889ghc:EducationMemberghc:SupplementalEducationMember2025-12-310000104889ghc:HealthcareDivisionMemberghc:CSIPharmacyMember2025-12-310000104889ghc:HealthcareDivisionMemberghc:OtherHealthcareMember2025-12-310000104889ghc:EducationMemberghc:HigherEducationMember2026-01-012026-03-310000104889ghc:EducationMemberghc:SupplementalEducationMember2026-01-012026-03-310000104889ghc:HealthcareDivisionMemberghc:CSIPharmacyMember2026-01-012026-03-310000104889ghc:HealthcareDivisionMemberghc:OtherHealthcareMember2026-01-012026-03-310000104889ghc:EducationMemberghc:KaplanInternationalMember2026-03-310000104889ghc:EducationMemberghc:HigherEducationMember2026-03-310000104889ghc:EducationMemberghc:SupplementalEducationMember2026-03-310000104889ghc:HealthcareDivisionMemberghc:CSIPharmacyMember2026-03-310000104889ghc:HealthcareDivisionMemberghc:OtherHealthcareMember2026-03-310000104889srt:MinimumMemberus-gaap:CustomerRelationshipsMember2026-03-310000104889srt:MinimumMemberus-gaap:CustomerRelationshipsMember2025-12-310000104889srt:MaximumMemberus-gaap:CustomerRelationshipsMember2025-12-310000104889srt:MaximumMemberus-gaap:CustomerRelationshipsMember2026-03-310000104889us-gaap:CustomerRelationshipsMember2026-03-310000104889us-gaap:CustomerRelationshipsMember2025-12-310000104889srt:MinimumMemberus-gaap:TrademarksAndTradeNamesMember2025-12-310000104889srt:MinimumMemberus-gaap:TrademarksAndTradeNamesMember2026-03-310000104889srt:MaximumMemberus-gaap:TrademarksAndTradeNamesMember2025-12-310000104889srt:MaximumMemberus-gaap:TrademarksAndTradeNamesMember2026-03-310000104889us-gaap:TrademarksAndTradeNamesMember2026-03-310000104889us-gaap:TrademarksAndTradeNamesMember2025-12-310000104889us-gaap:ContractBasedIntangibleAssetsMember2026-03-310000104889us-gaap:ContractBasedIntangibleAssetsMember2025-12-310000104889srt:MinimumMemberus-gaap:DatabasesMember2026-03-310000104889srt:MinimumMemberus-gaap:DatabasesMember2025-12-310000104889srt:MaximumMemberus-gaap:DatabasesMember2026-03-310000104889srt:MaximumMemberus-gaap:DatabasesMember2025-12-310000104889us-gaap:DatabasesMember2026-03-310000104889us-gaap:DatabasesMember2025-12-310000104889srt:MinimumMemberus-gaap:OtherIntangibleAssetsMember2026-03-310000104889srt:MinimumMemberus-gaap:OtherIntangibleAssetsMember2025-12-310000104889srt:MaximumMemberus-gaap:OtherIntangibleAssetsMember2026-03-310000104889srt:MaximumMemberus-gaap:OtherIntangibleAssetsMember2025-12-310000104889us-gaap:OtherIntangibleAssetsMember2026-03-310000104889us-gaap:OtherIntangibleAssetsMember2025-12-310000104889us-gaap:FranchiseRightsMember2026-03-310000104889us-gaap:FranchiseRightsMember2025-12-310000104889us-gaap:TrademarksAndTradeNamesMember2026-03-310000104889us-gaap:TrademarksAndTradeNamesMember2025-12-310000104889us-gaap:OperatingAndBroadcastRightsMember2026-03-310000104889us-gaap:OperatingAndBroadcastRightsMember2025-12-310000104889us-gaap:OtherIntangibleAssetsMember2026-03-310000104889us-gaap:OtherIntangibleAssetsMember2025-12-310000104889ghc:FivePointSixTwoFivePercentUnsecuredNotesMaturingIn2033Member2026-03-310000104889ghc:FivePointSixTwoFivePercentUnsecuredNotesMaturingIn2033Member2025-12-310000104889srt:MinimumMemberghc:FiveYearCreditAgreementMaturingIn2030Member2026-03-310000104889srt:MaximumMemberghc:FiveYearCreditAgreementMaturingIn2030Member2026-03-310000104889ghc:FiveYearCreditAgreementMaturingIn2030Member2026-03-310000104889ghc:FiveYearCreditAgreementMaturingIn2030Member2025-12-310000104889srt:MinimumMemberghc:RealEstateTermLoanMaturingIn2028Member2026-03-310000104889srt:MaximumMemberghc:RealEstateTermLoanMaturingIn2028Member2026-03-310000104889ghc:RealEstateTermLoanMaturingIn2028Member2026-03-310000104889ghc:RealEstateTermLoanMaturingIn2028Member2025-12-310000104889srt:MinimumMemberghc:CapitalTermLoanMaturingIn2028Member2026-03-310000104889srt:MaximumMemberghc:CapitalTermLoanMaturingIn2028Member2026-03-310000104889ghc:CapitalTermLoanMaturingIn2028Member2026-03-310000104889ghc:CapitalTermLoanMaturingIn2028Member2025-12-310000104889srt:MinimumMemberghc:OtherIndebtednessMember2026-03-310000104889srt:MaximumMemberghc:OtherIndebtednessMember2026-03-310000104889ghc:FivePointSixTwoFivePercentUnsecuredNotesMaturingIn2033Member2025-11-240000104889ghc:FivePointSevenFivePercentUnsecuredNotesMaturingIn2026Member2025-11-242025-11-240000104889ghc:FivePointSevenFivePercentUnsecuredNotesMaturingIn2026Member2025-11-240000104889ghc:TermLoanMaturingIn2027Member2025-11-242025-11-240000104889us-gaap:DelayedDrawTermLoanMemberghc:AutomotiveMember2025-10-210000104889ghc:FiveYearCreditAgreementMaturingIn2030Member2025-11-240000104889ghc:USDRevolvingCreditFacilityBorrowingsMember2026-03-310000104889us-gaap:SecuredOvernightFinancingRateSofrMemberghc:USDRevolvingCreditFacilityBorrowingsMember2026-01-012026-03-310000104889us-gaap:PrimeRateMemberghc:USDRevolvingCreditFacilityBorrowingsMember2026-01-012026-03-310000104889ghc:GBPRevolvingCreditFacilityBorrowingsMember2026-03-310000104889ghc:SterlingOvernightInterbankAverageRateSONIAMemberghc:GBPRevolvingCreditFacilityBorrowingsMember2026-01-012026-03-310000104889us-gaap:SecuritiesSubjectToMandatoryRedemptionMember2026-01-012026-03-310000104889us-gaap:SecuritiesSubjectToMandatoryRedemptionMember2025-01-012025-03-310000104889us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2026-03-310000104889us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2026-03-310000104889us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2026-03-310000104889us-gaap:FairValueMeasurementsRecurringMember2026-03-310000104889us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2025-12-310000104889us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2025-12-310000104889us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2025-12-310000104889us-gaap:FairValueMeasurementsRecurringMember2025-12-310000104889ghc:ContingentConsiderationLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2025-12-310000104889ghc:MandatorilyRedeemableNoncontrollingInterestMemberus-gaap:FairValueInputsLevel3Member2025-12-310000104889ghc:ContingentConsiderationLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2026-01-012026-03-310000104889ghc:MandatorilyRedeemableNoncontrollingInterestMemberus-gaap:FairValueInputsLevel3Member2026-01-012026-03-310000104889ghc:ContingentConsiderationLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2026-03-310000104889ghc:MandatorilyRedeemableNoncontrollingInterestMemberus-gaap:FairValueInputsLevel3Member2026-03-310000104889ghc:ContingentConsiderationLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2024-12-310000104889ghc:MandatorilyRedeemableNoncontrollingInterestMemberus-gaap:FairValueInputsLevel3Member2024-12-310000104889ghc:ContingentConsiderationLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2025-01-012025-03-310000104889ghc:MandatorilyRedeemableNoncontrollingInterestMemberus-gaap:FairValueInputsLevel3Member2025-01-012025-03-310000104889ghc:ContingentConsiderationLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2025-03-310000104889ghc:MandatorilyRedeemableNoncontrollingInterestMemberus-gaap:FairValueInputsLevel3Member2025-03-310000104889ghc:GrahamHoldingsCompanyMemberghc:GHCOneAndGHCTwoMember2026-01-012026-03-310000104889ghc:GroupofSeniorManagersofGHGMemberghc:GHCOneAndGHCTwoMember2026-01-012026-03-310000104889ghc:GHCOneAndGHCTwoMemberghc:GrahamHoldingsCompanyMember2026-01-012026-03-310000104889ghc:GHCOneAndGHCTwoMemberghc:GHCOneAndGHCTwoMemberghc:GroupofSeniorManagersofGHGMember2026-03-310000104889ghc:GHCOneAndGHCTwoMemberghc:GroupofSeniorManagersofGHGMember2026-01-012026-03-310000104889country:US2026-01-012026-03-310000104889country:US2025-01-012025-03-310000104889us-gaap:NonUsMember2026-01-012026-03-310000104889us-gaap:NonUsMember2025-01-012025-03-310000104889us-gaap:TransferredOverTimeMember2026-01-012026-03-310000104889us-gaap:TransferredOverTimeMember2025-01-012025-03-310000104889us-gaap:TransferredAtPointInTimeMember2026-01-012026-03-310000104889us-gaap:TransferredAtPointInTimeMember2025-01-012025-03-310000104889ghc:KaplanInternationalMember2026-03-310000104889ghc:KaplanInternationalMemberus-gaap:LongTermContractWithCustomerMember2026-04-012026-03-310000104889ghc:KaplanInternationalMember2025-12-310000104889ghc:AdditionalContractAssetsMember2026-03-310000104889ghc:AdditionalContractAssetsMember2025-12-310000104889ghc:SupplementalEducationMemberus-gaap:LongTermContractWithCustomerMember2026-01-012026-03-310000104889ghc:SupplementalEducationMemberus-gaap:LongTermContractWithCustomerMember2026-04-012026-03-310000104889ghc:SupplementalEducationMemberus-gaap:LongTermContractWithCustomerMember2026-03-310000104889us-gaap:EmployeeStockOptionMember2026-01-012026-03-310000104889us-gaap:EmployeeStockOptionMember2025-01-012025-03-310000104889us-gaap:RestrictedStockMemberus-gaap:CommonClassBMember2026-01-012026-03-310000104889us-gaap:RestrictedStockMemberus-gaap:CommonClassBMember2025-01-012025-03-310000104889ghc:ContingentlyIssuableSharesMemberus-gaap:CommonClassBMember2026-01-012026-03-310000104889ghc:ContingentlyIssuableSharesMemberus-gaap:CommonClassBMember2025-01-012025-03-310000104889us-gaap:PensionPlansDefinedBenefitMember2026-01-012026-03-310000104889us-gaap:PensionPlansDefinedBenefitMember2025-01-012025-03-310000104889ghc:SeparationIncentiveProgramMemberus-gaap:PensionPlansDefinedBenefitMemberghc:KaplanGrahamMediaGroupJoyceDekkoFramebridgeCode3SlateAndCorporateMember2026-01-012026-03-310000104889ghc:SeparationIncentiveProgramMemberus-gaap:PensionPlansDefinedBenefitMemberghc:WorldOfGoodBrandsMember2025-01-012025-03-310000104889us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember2026-01-012026-03-310000104889us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember2025-01-012025-03-310000104889us-gaap:DefinedBenefitPlanEquitySecuritiesUsMemberus-gaap:PensionPlansDefinedBenefitMember2026-03-310000104889us-gaap:DefinedBenefitPlanEquitySecuritiesUsMemberus-gaap:PensionPlansDefinedBenefitMember2025-12-310000104889us-gaap:PrivateEquityFundsMemberus-gaap:PensionPlansDefinedBenefitMember2026-03-310000104889us-gaap:PrivateEquityFundsMemberus-gaap:PensionPlansDefinedBenefitMember2025-12-310000104889us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:PensionPlansDefinedBenefitMember2026-03-310000104889us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:PensionPlansDefinedBenefitMember2025-12-310000104889ghc:FixedIncomeSecuritiesUSMemberus-gaap:PensionPlansDefinedBenefitMember2026-03-310000104889ghc:FixedIncomeSecuritiesUSMemberus-gaap:PensionPlansDefinedBenefitMember2025-12-310000104889us-gaap:PensionPlansDefinedBenefitMember2026-03-310000104889us-gaap:PensionPlansDefinedBenefitMember2025-12-310000104889ghc:AlphabetAndBerkshireHathawayCommonStockMemberus-gaap:PensionPlansDefinedBenefitMemberghc:InvestmentManager1Member2026-01-012026-03-310000104889us-gaap:PensionPlansDefinedBenefitMembersrt:MaximumMemberghc:ForeignInvestmentsMemberghc:InvestmentManager1Member2026-03-310000104889ghc:BerkshireHathawayCommonStockMemberus-gaap:PensionPlansDefinedBenefitMemberghc:InvestmentManager2Member2026-01-012026-03-310000104889us-gaap:PensionPlansDefinedBenefitMembersrt:MaximumMemberghc:ForeignInvestmentsMemberghc:InvestmentManager2Member2026-03-310000104889ghc:SingleEquityConcentrationMemberus-gaap:PensionPlansDefinedBenefitMember2026-01-012026-03-310000104889us-gaap:PensionPlansDefinedBenefitMemberghc:ConcentrationInSingleEntityTypeOfIndustryForeignCountryOrIndividualFundMemberghc:DefinedBenefitPlanAssetsTotalMember2026-01-012026-03-310000104889us-gaap:PensionPlansDefinedBenefitMemberghc:SingleEquityConcentrationMemberus-gaap:EquitySecuritiesMember2026-03-310000104889us-gaap:PensionPlansDefinedBenefitMemberghc:SingleEquityConcentrationMemberus-gaap:PrivateEquityFundsMember2026-03-310000104889ghc:SingleEquityConcentrationMemberus-gaap:PensionPlansDefinedBenefitMember2026-03-310000104889us-gaap:PensionPlansDefinedBenefitMemberghc:SingleEquityConcentrationMemberus-gaap:EquitySecuritiesMember2025-12-310000104889us-gaap:PensionPlansDefinedBenefitMemberghc:SingleEquityConcentrationMemberus-gaap:PrivateEquityFundsMember2025-12-310000104889us-gaap:PensionPlansDefinedBenefitMemberghc:ConcentrationInSingleEntityTypeOfIndustryForeignCountryOrIndividualFundMemberghc:DefinedBenefitPlanAssetsTotalMember2025-01-012025-06-300000104889ghc:SingleEquityConcentrationMemberus-gaap:PensionPlansDefinedBenefitMember2025-12-310000104889ghc:MarkelGroupIncMemberus-gaap:PensionPlansDefinedBenefitMember2026-03-310000104889ghc:MarkelGroupIncMemberus-gaap:PensionPlansDefinedBenefitMember2025-12-310000104889us-gaap:AccumulatedTranslationAdjustmentMember2026-01-012026-03-310000104889us-gaap:AccumulatedTranslationAdjustmentMember2025-01-012025-03-310000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2026-01-012026-03-310000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2025-01-012025-03-310000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2026-01-012026-03-310000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2025-01-012025-03-310000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2026-01-012026-03-310000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-01-012025-03-310000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2026-01-012026-03-310000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2025-01-012025-03-310000104889us-gaap:AccumulatedTranslationAdjustmentMember2025-12-310000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-12-310000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2025-12-310000104889us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2025-12-310000104889us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2026-01-012026-03-310000104889us-gaap:AccumulatedTranslationAdjustmentMember2026-03-310000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2026-03-310000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2026-03-310000104889us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2026-03-310000104889us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2026-01-012026-03-310000104889us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2025-01-012025-03-310000104889us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2026-01-012026-03-310000104889us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310000104889srt:MaximumMember2026-03-310000104889ghc:HigherEducationMemberghc:PurdueUniversityGlobalMemberghc:EducationMember2026-03-310000104889ghc:KaplanUniversityTransactionMemberghc:HigherEducationMemberghc:PurdueUniversityGlobalMemberghc:EducationMember2026-03-310000104889us-gaap:OperatingSegmentsMemberghc:EducationMember2026-01-012026-03-310000104889us-gaap:OperatingSegmentsMemberghc:TelevisionBroadcastingMember2026-01-012026-03-310000104889us-gaap:OperatingSegmentsMemberghc:HealthcareDivisionMember2026-01-012026-03-310000104889us-gaap:OperatingSegmentsMemberghc:ManufacturingMember2026-01-012026-03-310000104889us-gaap:OperatingSegmentsMemberghc:AutomotiveMember2026-01-012026-03-310000104889us-gaap:OperatingSegmentsMemberus-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember2026-01-012026-03-310000104889us-gaap:OperatingSegmentsMemberus-gaap:CorporateAndOtherMember2026-01-012026-03-310000104889us-gaap:IntersegmentEliminationMember2026-01-012026-03-310000104889us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMember2026-01-012026-03-310000104889us-gaap:CorporateNonSegmentMember2026-01-012026-03-310000104889us-gaap:OperatingSegmentsMemberus-gaap:ReportableSubsegmentsMemberghc:KaplanInternationalMemberghc:EducationMember2026-01-012026-03-310000104889us-gaap:OperatingSegmentsMemberus-gaap:ReportableSubsegmentsMemberghc:HigherEducationMemberghc:EducationMember2026-01-012026-03-310000104889us-gaap:OperatingSegmentsMemberus-gaap:ReportableSubsegmentsMemberghc:SupplementalEducationMemberghc:EducationMember2026-01-012026-03-310000104889us-gaap:OperatingSegmentsMemberghc:KaplanCorporateAndOtherMemberghc:EducationMember2026-01-012026-03-310000104889us-gaap:OperatingSegmentsMemberus-gaap:IntersubsegmentEliminationsMemberghc:EducationMember2026-01-012026-03-310000104889us-gaap:OperatingSegmentsMemberus-gaap:ReportableSubsegmentsMemberghc:CSIPharmacyMemberghc:HealthcareDivisionMember2026-01-012026-03-310000104889us-gaap:OperatingSegmentsMemberghc:OtherHealthcareMemberghc:HealthcareDivisionMember2026-01-012026-03-310000104889us-gaap:OperatingSegmentsMemberghc:EducationMember2025-01-012025-03-310000104889us-gaap:OperatingSegmentsMemberghc:TelevisionBroadcastingMember2025-01-012025-03-310000104889us-gaap:OperatingSegmentsMemberghc:HealthcareDivisionMember2025-01-012025-03-310000104889us-gaap:OperatingSegmentsMemberghc:ManufacturingMember2025-01-012025-03-310000104889us-gaap:OperatingSegmentsMemberghc:AutomotiveMember2025-01-012025-03-310000104889us-gaap:OperatingSegmentsMemberus-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember2025-01-012025-03-310000104889us-gaap:OperatingSegmentsMemberus-gaap:CorporateAndOtherMember2025-01-012025-03-310000104889us-gaap:IntersegmentEliminationMember2025-01-012025-03-310000104889us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMember2025-01-012025-03-310000104889us-gaap:CorporateNonSegmentMember2025-01-012025-03-310000104889us-gaap:OperatingSegmentsMemberus-gaap:ReportableSubsegmentsMemberghc:KaplanInternationalMemberghc:EducationMember2025-01-012025-03-310000104889us-gaap:OperatingSegmentsMemberus-gaap:ReportableSubsegmentsMemberghc:HigherEducationMemberghc:EducationMember2025-01-012025-03-310000104889us-gaap:OperatingSegmentsMemberus-gaap:ReportableSubsegmentsMemberghc:SupplementalEducationMemberghc:EducationMember2025-01-012025-03-310000104889us-gaap:OperatingSegmentsMemberghc:KaplanCorporateAndOtherMemberghc:EducationMember2025-01-012025-03-310000104889us-gaap:OperatingSegmentsMemberus-gaap:IntersubsegmentEliminationsMemberghc:EducationMember2025-01-012025-03-310000104889us-gaap:OperatingSegmentsMemberus-gaap:ReportableSubsegmentsMemberghc:CSIPharmacyMemberghc:HealthcareDivisionMember2025-01-012025-03-310000104889us-gaap:OperatingSegmentsMemberghc:OtherHealthcareMemberghc:HealthcareDivisionMember2025-01-012025-03-310000104889us-gaap:OperatingSegmentsMemberus-gaap:ReportableSubsegmentsMemberghc:KaplanInternationalMemberghc:EducationMember2026-03-310000104889us-gaap:OperatingSegmentsMemberus-gaap:ReportableSubsegmentsMemberghc:KaplanInternationalMemberghc:EducationMember2025-12-310000104889us-gaap:OperatingSegmentsMemberus-gaap:ReportableSubsegmentsMemberghc:HigherEducationMemberghc:EducationMember2026-03-310000104889us-gaap:OperatingSegmentsMemberus-gaap:ReportableSubsegmentsMemberghc:HigherEducationMemberghc:EducationMember2025-12-310000104889us-gaap:OperatingSegmentsMemberus-gaap:ReportableSubsegmentsMemberghc:SupplementalEducationMemberghc:EducationMember2026-03-310000104889us-gaap:OperatingSegmentsMemberus-gaap:ReportableSubsegmentsMemberghc:SupplementalEducationMemberghc:EducationMember2025-12-310000104889us-gaap:OperatingSegmentsMemberghc:KaplanCorporateAndOtherMemberghc:EducationMember2026-03-310000104889us-gaap:OperatingSegmentsMemberghc:KaplanCorporateAndOtherMemberghc:EducationMember2025-12-310000104889us-gaap:OperatingSegmentsMemberghc:EducationMember2026-03-310000104889us-gaap:OperatingSegmentsMemberghc:EducationMember2025-12-310000104889us-gaap:OperatingSegmentsMemberghc:TelevisionBroadcastingMember2026-03-310000104889us-gaap:OperatingSegmentsMemberghc:TelevisionBroadcastingMember2025-12-310000104889us-gaap:OperatingSegmentsMemberus-gaap:ReportableSubsegmentsMemberghc:CSIPharmacyMemberghc:HealthcareDivisionMember2026-03-310000104889us-gaap:OperatingSegmentsMemberus-gaap:ReportableSubsegmentsMemberghc:CSIPharmacyMemberghc:HealthcareDivisionMember2025-12-310000104889us-gaap:OperatingSegmentsMemberghc:OtherHealthcareMemberghc:HealthcareDivisionMember2026-03-310000104889us-gaap:OperatingSegmentsMemberghc:OtherHealthcareMemberghc:HealthcareDivisionMember2025-12-310000104889us-gaap:OperatingSegmentsMemberghc:HealthcareDivisionMember2026-03-310000104889us-gaap:OperatingSegmentsMemberghc:HealthcareDivisionMember2025-12-310000104889us-gaap:OperatingSegmentsMemberghc:ManufacturingMember2026-03-310000104889us-gaap:OperatingSegmentsMemberghc:ManufacturingMember2025-12-310000104889us-gaap:OperatingSegmentsMemberghc:AutomotiveMember2026-03-310000104889us-gaap:OperatingSegmentsMemberghc:AutomotiveMember2025-12-310000104889us-gaap:OperatingSegmentsMemberus-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember2026-03-310000104889us-gaap:OperatingSegmentsMemberus-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember2025-12-310000104889us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMember2026-03-310000104889us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMember2025-12-310000104889us-gaap:CorporateNonSegmentMember2026-03-310000104889us-gaap:CorporateNonSegmentMember2025-12-31

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 10-Q


☒			Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Quarterly Period Ended March 31, 2026


☐			Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Commission File Number 001-06714

GRAHAM HOLDINGS COMPANY


(Exact name of registrant as specified in its charter)

Delaware

53-0182885

(State or other jurisdiction of
incorporation or organization)

(I.R.S. Employer
Identification No.)

1812 North Moore Street, Arlington, Virginia

22209

(Address of principal executive offices)

(Zip Code)

(703) 345-6300

(Registrant’s telephone number, including area code)

Securities Registered Pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Class B Common Stock, par value $1.00 per share

GHC

New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒. No ☐.

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒. No ☐.

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer

☒

Accelerated
filer

☐

Non-accelerated
filer

☐

Smaller reporting
company

☐

Emerging growth
company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐. No ☒.

Shares outstanding at April 24, 2026:

Class A Common Stock – 964,001 Shares

Class B Common Stock – 3,343,083 Shares

GRAHAM HOLDINGS COMPANY

Index to Form 10-Q


PART I. FINANCIAL INFORMATION

Item 1.	Financial Statements

	Condensed Consolidated Statements of Operations	1

	Condensed Consolidated Statements of Comprehensive Income	2

	Condensed Consolidated Balance Sheets	3

	Condensed Consolidated Statements of Cash Flows	4

	Condensed Consolidated Statements of Changes in Common Stockholders' Equity	5

	Notes to Condensed Consolidated Financial Statements	6

	Organization, Basis of Presentation and Recent Accounting Pronouncements	6
	Acquisitions and Dispositions of Businesses	7
	Investments	10
	Accounts Receivable, Accounts Payable, Vehicle Floor Plan Payable and Accrued Liabilities	11
	Inventories and Contracts in Progress	12
	Goodwill and Other Intangible Assets	12
	Debt	13
	Fair Value Measurements	15

	Revenue From Contracts With Customers	16
	Earnings Per Share	17
	Pension Plans	18
	Other Non-Operating Expense	20
	Accumulated Other Comprehensive Income (Loss)	20
	Contingencies	21
	Business Segments	21

Item 2.	Management’s Discussion and Analysis of Results of Operations and Financial Condition	27

Item 3.	Quantitative and Qualitative Disclosures about Market Risk	37

Item 4.	Controls and Procedures	37

PART II. OTHER INFORMATION



Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	38

Item 5.	Other Information	38

Item 6.	Exhibits	39

Signatures		40

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements.

GRAHAM HOLDINGS COMPANY

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)


	Three Months Ended March 31

(in thousands, except per share amounts)		2026		2025
Operating Revenues
Sales of services		$	673,799	$	647,507
Sales of goods		562,193		518,408
		1,235,992		1,165,915
Operating Costs and Expenses
Cost of services sold (exclusive of items shown below)		394,993		386,136
Cost of goods sold (exclusive of items shown below)		462,207		433,222
Selling, general and administrative		277,481		270,706
Depreciation of property, plant and equipment		18,394		20,554
Amortization of intangible assets		6,055		7,824
Impairment of goodwill and asset group held for sale		19,029		—
		1,178,159		1,118,442
Income from Operations		57,833		47,473
Equity in earnings (losses) of affiliates, net		34,850		(8,428)
Interest income		2,475		2,500
Interest expense		(16,229)		(82,277)
Non-operating pension and postretirement benefit income, net		31,073		34,617
(Loss) gain on marketable equity securities, net		(68,923)		43,801
Other expense, net		(428)		(4,065)
Income Before Income Taxes		40,651		33,621
Provision for Income Taxes		9,900		7,900
Net Income		30,751		25,721
Net Income Attributable to Noncontrolling Interests		(1,645)		(1,827)
Net Income Attributable to Graham Holdings Company Common Stockholders		$	29,106	$	23,894

Per Share Information Attributable to Graham Holdings Company Common Stockholders
Basic net income per common share		$	6.68	$	5.50
Basic average number of common shares outstanding		4,331		4,320
Diluted net income per common share		$	6.62	$	5.45
Diluted average number of common shares outstanding		4,375		4,358

See accompanying Notes to Condensed Consolidated Financial Statements.

GRAHAM HOLDINGS COMPANY

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)


	Three Months Ended March 31
(in thousands)		2026		2025
Net Income		$	30,751	$	25,721
Other Comprehensive (Loss) Income, Before Tax
Foreign currency translation adjustments:


Translation adjustments arising during the period		(6,248)		14,267
Pension and other postretirement plans:
Amortization of net prior service credit included in net income		(496)		(519)
Amortization of net actuarial gain included in net income		(258)		(379)

		(754)		(898)
Cash flow hedges gain (loss)		626		(679)
Other Comprehensive (Loss) Income, Before Tax		(6,376)		12,690
Income tax benefit related to items of other comprehensive (loss) income		34		406
Other Comprehensive (Loss) Income, Net of Tax		(6,342)		13,096
Comprehensive Income		24,409		38,817
Comprehensive income attributable to noncontrolling interests		(1,645)		(1,827)
Total Comprehensive Income Attributable to Graham Holdings Company		$	22,764	$	36,990

See accompanying Notes to Condensed Consolidated Financial Statements.

GRAHAM HOLDINGS COMPANY

CONDENSED CONSOLIDATED BALANCE SHEETS


	As of
(in thousands)	March 31, 2026		December 31, 2025
	(Unaudited)
Assets
Current Assets
Cash and cash equivalents	$	135,676	$	266,988
Restricted cash	63,439		44,417
Investments in marketable equity securities and other investments	972,701		1,088,970
Accounts receivable, net	520,482		576,754

Inventories and contracts in progress	306,892		303,370
Prepaid expenses	135,826		124,875
Income taxes receivable	14,788		15,447
Other current assets	10,011		10,274
Current assets held for sale (includes $28,801 of cash and $6,041 of restricted cash)	49,140		—
Total Current Assets	2,208,955		2,431,095
Property, Plant and Equipment, Net	576,348		587,434
Lease Right-of-Use Assets	387,163		404,818
Investments in Affiliates	237,053		229,565
Goodwill, Net	1,599,489		1,585,666
Indefinite-Lived Intangible Assets	170,321		170,805
Amortized Intangible Assets, Net	55,115		61,631
Prepaid Pension Cost	2,792,300		2,772,394
Deferred Income Taxes	9,913		9,690
Deferred Charges and Other Assets	129,683		142,615
Noncurrent Assets Held for Sale	14,149		—
Total Assets	$	8,180,489	$	8,395,713

Liabilities and Equity
Current Liabilities
Accounts payable, vehicle floor plan payable and accrued liabilities	$	627,428	$	721,626
Deferred revenue	361,621		411,651
Income taxes payable	7,368		8,995

Mandatorily redeemable noncontrolling interest	6,033		6,874
Current portion of lease liabilities	58,581		64,290
Current portion of long-term debt	107,098		175,138
Dividends declared	8,198		—

Current liabilities held for sale	56,002		—
Total Current Liabilities	1,232,329		1,388,574

Accrued Compensation and Related Benefits	131,641		135,323
Other Liabilities	28,122		28,639
Deferred Income Taxes	896,992		890,984
Mandatorily Redeemable Noncontrolling Interest	1,603		1,527
Lease Liabilities	365,847		377,897
Long-Term Debt	714,884		705,618
Noncurrent Liabilities Held for Sale	12,347		—
Total Liabilities	3,383,765		3,528,562
Commitments and Contingencies (Note 14)

Redeemable Noncontrolling Interests	29,920		39,824
Preferred Stock	—		—
Common Stockholders’ Equity
Common stock	20,000		20,000
Capital in excess of par value	346,943		379,896
Retained earnings	8,305,389		8,292,681
Accumulated other comprehensive income, net of taxes
Cumulative foreign currency translation adjustment	(18,510)		(12,262)

Unrealized gain on pensions and other postretirement plans	600,507		601,064
Cash flow hedges	(1,259)		(1,722)
Cost of Class B common stock held in treasury	(4,520,318)		(4,485,632)
Total Common Stockholders’ Equity	4,732,752		4,794,025
Noncontrolling Interests	34,052		33,302
Total Equity	4,766,804		4,827,327
Total Liabilities and Equity	$	8,180,489	$	8,395,713

See accompanying Notes to Condensed Consolidated Financial Statements.

GRAHAM HOLDINGS COMPANY

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)


	Three Months Ended March 31
(in thousands)	2026		2025
Cash Flows from Operating Activities
Net Income	$	30,751	$	25,721
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, amortization and goodwill and asset group held for sale impairment	43,478		28,378
Amortization of lease right-of-use asset	14,814		14,103
Net pension benefit and special separation benefit expense	(20,401)		(23,253)
Loss (gain) on marketable equity securities	68,923		(43,801)
(Gain) loss on disposition of property, plant and equipment and investments, net	(518)		276
Credit loss expense	1,540		1,140
Stock-based compensation expense, net of forfeitures	1,496		1,546
Foreign exchange loss	1,224		4,379
Equity in (earnings) losses of affiliates, net of distributions	(8,466)		12,241
Provision for deferred income taxes	2,743		941
Change in operating assets and liabilities:
Accounts receivable	48,469		16,550
Inventories	(2,155)		35,808
Accounts payable and accrued liabilities	(74,385)		(72,779)
Deferred revenue	(13,640)		3,443
Income taxes receivable/payable	(1,148)		(164)
Lease liabilities	(14,945)		(7,337)
Other assets and other liabilities, net	(10,647)		48,946
Other	599		(124)
Net Cash Provided by Operating Activities	67,732		46,014
Cash Flows from Investing Activities
Proceeds from sales of marketable equity securities	49,994		—
Purchases of property, plant and equipment	(19,171)		(15,482)
Investments in certain businesses, net of cash acquired	(18,162)		—
Purchases of marketable equity securities	(3,698)		(4,823)

Net proceeds from disposition of businesses, property, plant and equipment and investments	667		940



Other	870		775
Net Cash Provided by (Used in) Investing Activities	10,500		(18,590)
Cash Flows from Financing Activities
Net (payments) borrowings under revolving credit facilities	(68,210)		121,400
Common shares repurchased	(34,143)		(3,468)
Purchase of noncontrolling interests	(17,340)		—
Repayments of borrowings	(11,972)		(7,139)
Dividends paid	(8,200)		(7,813)
Net repayments of vehicle floor plan payable	(4,291)		(32,301)
Principal payments of finance leases	(3,837)		(4,441)
Distributions paid to noncontrolling interests	(3,235)		(188,253)





Other	(867)		288
Net Cash Used in Financing Activities	(152,095)		(121,727)
Effect of Currency Exchange Rate Change	(3,585)		3,388
Net Decrease in Cash and Cash Equivalents and Restricted Cash	(77,448)		(90,915)
Beginning Cash and Cash Equivalents and Restricted Cash	311,405		297,853
Ending Cash and Cash Equivalents and Restricted Cash	$	233,957	$	206,938

See accompanying Notes to Condensed Consolidated Financial Statements.

GRAHAM HOLDINGS COMPANY

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN COMMON STOCKHOLDERS’ EQUITY (UNAUDITED)


(in thousands)	Common Stock		Capital in Excess of Par Value		Retained Earnings		Accumulated Other Comprehensive Income		Treasury Stock		Noncontrolling Interest		Total Equity		Redeemable Noncontrolling Interest
As of December 31, 2025	$	20,000	$	379,896	$	8,292,681	$	587,080	$	(4,485,632)	$	33,302	$	4,827,327	$	39,824
Net income for the period					30,751								30,751
Net income attributable to noncontrolling interests					(699)						699		—
Net income attributable to redeemable noncontrolling interests					(946)								(946)		946
Change in redemption value of redeemable noncontrolling interest			(8,225)								(4)		(8,229)		8,250

Distributions to noncontrolling interests											(884)		(884)		(2,251)
Dividends on common stock					(16,398)								(16,398)
Repurchase of Class B common stock									(34,476)				(34,476)
Issuance of Class B common stock, net of restricted stock award forfeitures			(252)						224				(28)
Shares withheld related to net share settlement									(434)				(434)
Amortization of unearned stock compensation and stock option expense			1,525										1,525
Purchase of noncontrolling interest			(26,001)								939		(25,062)
Other comprehensive loss, net of income taxes							(6,342)						(6,342)
Purchase of redeemable noncontrolling interests													—		(16,849)
As of March 31, 2026	$	20,000	$	346,943	$	8,305,389	$	580,738	$	(4,520,318)	$	34,052	$	4,766,804	$	29,920






































(in thousands)	Common Stock		Capital in Excess of Par Value		Retained Earnings		Accumulated Other Comprehensive Income		Treasury Stock		Noncontrolling Interest		Total Equity		Redeemable Noncontrolling Interest
As of December 31, 2024	$	20,000	$	356,919	$	8,031,750	$	334,797	$	(4,486,805)	$	30,154	$	4,286,815	$	43,821
Net income for the period					25,721								25,721
Net income attributable to noncontrolling interests					(1,129)						1,129		—
Net income attributable to redeemable noncontrolling interests					(698)								(698)		698
Change in redemption value of redeemable noncontrolling interests											634		634		8
Noncontrolling interest capital contribution											180		180
Distributions to noncontrolling interests											(747)		(747)		(941)
Dividends on common stock					(15,662)								(15,662)
Repurchase of Class B common stock									(3,468)				(3,468)
Issuance of Class B common stock, net of restricted stock award forfeitures			9,431						9,141				18,572
Shares withheld related to net share settlement									(402)				(402)
Amortization of unearned stock compensation and stock option expense			1,724										1,724
Other comprehensive income, net of income taxes							13,096						13,096
As of March 31, 2025	$	20,000	$	368,074	$	8,039,982	$	347,893	$	(4,481,534)	$	31,350	$	4,325,765	$	43,586

See accompanying Notes to Condensed Consolidated Financial Statements.

GRAHAM HOLDINGS COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

1. ORGANIZATION, BASIS OF PRESENTATION AND RECENT ACCOUNTING PRONOUNCEMENTS

Graham Holdings Company (the Company), is a diversified holding company whose operations include educational services, television broadcasting, healthcare, manufacturing, automotive dealerships and other businesses.

Through Kaplan, Inc. (Kaplan), the Company provides a wide variety of educational services to students, schools, colleges, universities and businesses, both domestically and outside the United States (U.S.). Kaplan’s educational services include academic preparation programs for international students; English-language programs; operations support services for pre-college, certificate, undergraduate and graduate programs; exam preparation for high school and graduate students and for professional certifications and licensures; career and academic advisement services to businesses; and a United Kingdom (U.K.) sixth-form college that prepares students for A-level examinations.

The Company’s television broadcasting segment owns and operates seven television broadcasting stations and provides social media management tools designed to connect newsrooms with their users.

The Company’s healthcare division provides in-home specialty pharmacy infusion therapies; home health, hospice and palliative services; physician services for allergy, asthma and immunology patients; in-home aesthetics; applied behavior analysis therapy; and healthcare software-as-a-service technology.

The Company’s manufacturing companies include a supplier of pressure-treated wood and aluminum cladding products, a manufacturer of electrical solutions, a manufacturer of lifting solutions, and a supplier of parts used in electric utilities and industrial systems.

The Company’s automotive business comprises eight dealerships and valet repair services.

The Company’s other businesses include restaurants; a custom framing company; a marketing solutions provider; a customer data and analytics software company; Slate and Foreign Policy magazines; a daily local news podcast and newsletter company; a company that provides a software-as-a-service platform that enables podcasters and media companies to monetize audio content through paid subscriptions, memberships, and audiobooks; an online art gallery and in-person art fair business; and an online commerce platform featuring original art and designs on an array of consumer products.

On February 1, 2026, Kaplan entered into a Share Purchase Agreement to sell its Kaplan Languages Group (KLG) business, consisting of more than 20 language schools in eight countries. The transaction is expected to close on May 1, 2026.

Basis of Presentation – The accompanying condensed consolidated financial statements have been prepared in accordance with: (i) generally accepted accounting principles in the United States of America (GAAP) for interim financial information; (ii) the instructions to Form 10-Q; and (iii) the guidance of Rule 10-01 of Regulation S-X under the Securities and Exchange Act of 1934, as amended, for financial statements required to be filed with the Securities and Exchange Commission (SEC). They include the assets, liabilities, results of operations and cash flows of the Company, including its domestic and foreign subsidiaries that are more than 50% owned or otherwise controlled by the Company. As permitted under such rules, certain notes and other financial information normally required by GAAP have been condensed or omitted. Management believes the accompanying condensed consolidated financial statements reflect all normal and recurring adjustments necessary for a fair statement of the Company’s financial position, results of operations, and cash flows as of and for the periods presented herein. The Company’s results of operations for the three months ended March 31, 2026 and 2025 may not be indicative of the Company’s future results. These condensed consolidated financial statements are unaudited and should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025.

The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by GAAP.

Use of Estimates in the Preparation of the Condensed Consolidated Financial Statements – The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and judgments that affect the amounts reported herein. Management bases its estimates and assumptions on historical experience and on various other factors that are believed to be reasonable under the circumstances. Due to the inherent uncertainty involved in making estimates, actual results reported in future periods may be affected by changes in those estimates.

Assets Held for Sale – An asset or business is classified as held for sale when (i) management commits to a plan to sell the asset or business; (ii) the asset or business is available for immediate sale in its present condition; (iii) the asset or business is actively marketed for sale at a reasonable price; (iv) the sale is expected to be completed within one year; and (v) it is unlikely significant changes to the plan will be made or that the plan will be withdrawn. The assets and related liabilities are aggregated and reported separately in the Company’s Condensed Consolidated Financial Statements (see Note 2).

Recently Adopted and Issued Accounting Pronouncements – In November 2024, the Financial Accounting Standards Board (FASB) issued new guidance that requires disclosures about certain significant expense categories including inventory purchases, employee compensation, depreciation, amortization, and selling expenses. The guidance is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The Company is in the process of evaluating the impact of this new guidance on the disclosures within its Condensed Consolidated Financial Statements.

In September 2025, FASB issued new guidance which updates the accounting for internal-use software by removing references to software development project stages and adding new criteria to determine when an entity is required to start capitalizing internal-use software costs. The guidance is effective for fiscal years and interim periods beginning after December 15, 2027. Early adoption is permitted. The Company is in the process of evaluating the impact of this new guidance on its Condensed Consolidated Financial Statements.

2. ACQUISITIONS AND DISPOSITIONS OF BUSINESSES

Acquisitions. In March 2026, the Company acquired one small business which is included in other healthcare businesses. The assets and liabilities of the company acquired were recorded at their estimated fair values at the date of acquisition.

During 2025, the Company acquired five businesses: one in education, two in other healthcare businesses, one in manufacturing and one in automotive for $71.2 million in cash and the assumption of floor plan payables and $107.5 million in net pension obligations. The assets and liabilities of the companies acquired were recorded at their estimated fair values at the date of acquisition.

In June 2025, Kaplan acquired one small business which is included in its supplemental education division.

In July 2025, Hoover acquired 100% of Arconic Architectural Products, LLC, a wholly-owned subsidiary of Arconic Corporation, which manufactures aluminum cladding products and operates within the broader non-residential materials space from its facility in Eastman, GA. A significant portion of the purchase price was funded by the Company’s assumption of certain pension obligations. The acquisition expands Hoover’s product offerings and is included in manufacturing.

In October 2025, Graham Healthcare Group (GHG) acquired two small businesses which are included in other healthcare businesses.

In October 2025, the Company’s automotive subsidiary acquired a Honda automotive dealership, including the real property for the dealership operations. In addition to a cash payment and the assumption of $4.9 million in floor plan payables, the automotive subsidiary borrowed $38.7 million under the delayed draw term loan to finance the acquisition (see Note 7). The dealership is operated and managed by an entity affiliated with Christopher J. Ourisman, a member of the Ourisman Automotive Group family of dealerships. This acquisition expands the Company’s automotive business operations and is included in automotive.

Acquisition-related costs for the acquisition that closed during the first three months of 2026 were expensed as incurred. The aggregate purchase price of the 2025 acquisitions was allocated as follows, based on the acquisition date fair values to the following assets and liabilities:


	Purchase Price Allocation
	Year Ended
(in thousands)	December 31, 2025
Accounts receivable	$	11,641
Inventory	32,731
Property, plant and equipment	35,920
Lease right-of-use assets	3,642
Goodwill	51,943
Indefinite-lived intangible assets	15,500
Amortized intangible assets	41,300
Deferred income taxes	13,947
Other assets	221
Pension liabilities	(107,517)
Floor plan payables	(4,939)
Other liabilities	(18,371)
Current and noncurrent lease liabilities	(4,783)


Aggregate purchase price, net of cash acquired	$	71,235

Goodwill is calculated as the excess of the consideration transferred over the net assets recognized and represents the estimated future economic benefits arising from other assets acquired that could not be individually identified and separately recognized. The goodwill recorded due to these acquisitions is attributable to the assembled workforces of the acquired companies and expected synergies. The Company expects to deduct $12.4 million of goodwill for income tax purposes for the acquisitions completed in 2025.

The acquired companies were consolidated into the Company’s financial statements starting on their respective acquisition dates. The following unaudited pro forma financial information includes the 2025 acquisitions as if they occurred at the beginning of 2024:


	Three Months Ended March 31
(in thousands)		2025
Operating revenues		$	1,213,392
Net income		27,084

These pro forma results were based on estimates and assumptions, which the Company believes are reasonable, and include the historical results of operations of the acquired companies and adjustments for depreciation and amortization of identified assets and the effect of pre-acquisition transaction related expenses incurred by the Company and the acquired entities. The pro forma information does not include efficiencies, cost reductions and synergies expected to result from the acquisitions. They are not the results that would have been realized had these entities been part of the Company during the periods presented and are not necessarily indicative of the Company’s consolidated results of operations in future periods.

Disposition of Businesses. During the first quarter of 2026, Kaplan entered into a Share Purchase Agreement to sell the KLG business, which is included in Kaplan international. KLG comprises Kaplan International Languages, Alpadia Language Schools, Azurlingua and English as a second language (ESL) Education. As a result, the Company classified the assets and liabilities of KLG as held for sale in the Company’s Condensed Consolidated Balance Sheet as of March 31, 2026. The sale is expected to close on May 1, 2026.

The carrying amounts of the major classes of assets and liabilities of the KLG disposal group classified as held for sale as of March 31, 2026 are as follows:


	As of
(in thousands)	March 31, 2026
Cash and cash equivalents	$	28,801
Restricted cash	6,041
Accounts receivable, net	7,779
Prepaid expenses	5,934
Other current assets	585
Current Assets Held for Sale	49,140
Property, plant and equipment, net	8,106
Lease right-of-use assets	19,772
Amortized intangible assets, net	458
Deferred charges and other assets	2,400
Valuation allowance on assets held for sale	(16,587)
Noncurrent Assets Held for Sale	$	14,149

Accounts payable and accrued liabilities	$	18,877
Deferred revenue	31,696
Income taxes payable	(35)
Current portion of lease liabilities	5,464
Current Liabilities Held for Sale	56,002
Other liabilities	1,768
Deferred income taxes	(3,545)
Lease liabilities	14,124
Noncurrent Liabilities Held for Sale	$	12,347

The Company measures the assets and liabilities of a disposal group classified as held for sale at the lower of its carrying value or fair value less costs to sell. The Company determined that the fair value less costs to sell of the KLG disposal group did not exceed its carrying value. As a result, upon classification of the KLG disposal group as held for sale, the Company recognized total impairment charges of $19.0 million, consisting of a $1.0 million goodwill impairment charge and an $18.0 million impairment charge related to the asset group held for sale. This resulted in the Company recording a $16.6 million valuation allowance in order to reduce the carrying value of the KLG disposal group to its fair value less costs to sell. The Company used a market approach to estimate the fair value of the KLG disposal group.

In early September 2025, the Company ceased operations of the Ourisman Jeep of Bethesda dealership.

In April 2025, Kaplan completed the sale of a small business, BridgeU Limited, which was included in Kaplan International.

In the first half of 2025, World of Good Brands (WGB) completed the sale of various websites and related businesses that made up the WGB operations, which were included in other businesses. All remaining WGB operations were substantially shut down by the end of the third quarter of 2025.

Other Transactions. In March 2026, the Company acquired some of the minority-owned shares of CSI Pharmacy Holding Company, LLC (CSI) for a total amount of $41.0 million. The Company paid cash of $16.4 million and entered into promissory notes with the minority owners for the remaining $24.6 million at an interest rate of 8% per annum. The notes are included in other indebtedness (see Note 7) and payable in quarterly installments with the final payment due on April 1, 2028. Following the redemption, the Company owns 93.4% of CSI.

In January 2026, pursuant to the exercise of a put right, the Company purchased some of the minority-owned interest of Clarus for $1.0 million. Following the redemption, the Company owns 97.5% of Clarus.

In October 2025, pursuant to the exercise of a put right, the Company purchased some of the minority-owned interest of Clarus for $0.4 million. Following the redemption, the Company owned 95.75% of Clarus.

In July 2025, CSI exercised its call option to purchase some of the minority-owned interest of CSI for $1.8 million.

On February 25, 2025, the Company and a group of minority shareholders entered into an agreement to settle a significant portion of the mandatorily redeemable noncontrolling interest related to GHC One LLC (GHC One), including CSI, for a total of $205 million, which consisted of approximately $186.25 million in cash and $18.75 million in Graham Holdings Company Class B common stock.

The settlement agreement resulted in a $66.2 million increase to the mandatorily redeemable noncontrolling interest obligation, which the Company recorded as interest expense in the first quarter of 2025. The remaining mandatorily redeemable noncontrolling interest obligation related to GHC One and GHC Two LLC (GHC Two) was $7.6 million at March 31, 2026, with $6.0 million included in current liabilities due to the expected dissolution of GHC One within one year.

In December 2024, the Company acquired some of the minority-owned shares of CSI for a total estimated amount of $2.0 million. The Company paid cash of $0.6 million and entered into a promissory note with the minority owner for the remaining $1.4 million at an interest rate of 5.5% per annum. The note was included in other indebtedness (see Note 7) and was due and payable on January 31, 2026. Following the redemption, the Company owned 87.5% of CSI. Pursuant to the terms of the purchase agreement, the purchase price was finalized in December 2025, resulting in an additional amount payable of $0.1 million, plus interest at 5.5% per annum, to the minority owner. The note was subsequently paid in the first quarter of 2026.

As of March 31, 2026, the Company holds a controlling financial interest in GHC One and GHC Two and therefore includes the assets, liabilities, results of operations and cash flows in its consolidated financial statements. GHC One acquired Clarus during 2019. GHC Two acquired Impact Medical during 2021 and Skin Clique and Surpass in 2022. The Company accounts for the minority ownership of the group of current and former senior managers in GHC One and GHC Two as a mandatorily redeemable noncontrolling interest (see Note 8).

3. INVESTMENTS

Money Market Investments. As of March 31, 2026 and December 31, 2025, the Company had money market investments of $7.5 million and $5.3 million, respectively, that are classified as cash and cash equivalents in the Company’s Condensed Consolidated Balance Sheets.

Investments in Marketable Equity Securities. Investments in marketable equity securities consist of the following:


	As of
	March 31, 2026		December 31, 2025
(in thousands)
Total cost	$	256,059	$	256,897
Gross unrealized gains	736,466		845,889
Gross unrealized losses	(25,806)		(20,848)
Total Fair Value	$	966,719	$	1,081,938

At March 31, 2026 and December 31, 2025, the Company owned 55,430 shares in Markel Group Inc. (Markel) valued at $106.1 million and $119.2 million, respectively. The Chief Executive Officer of Markel, Mr. Thomas S. Gayner, is a member of the Company’s Board of Directors. As of March 31, 2026, the Company owned 422 Class A and 481,920 Class B shares in Berkshire Hathaway valued at $534.0 million, which exceeded 5% of the Company’s total assets.

The Company purchased $3.7 million and $4.8 million of marketable equity securities during the first three months of 2026 and 2025, respectively. During the first three months of 2026, the gross cumulative realized net gains from the sales of marketable equity securities were $45.5 million. The total proceeds from such sales were $50.0 million. There were no sales of marketable equity securities during the first three months of 2025.

The net (loss) gain on marketable equity securities comprised the following:


	Three Months Ended March 31
(in thousands)		2026		2025
(Loss) gain on marketable equity securities, net		$	(68,923)	$	43,801
Less: Net gains in earnings from marketable equity securities sold		(2,367)		—
Net unrealized (losses) gains in earnings from marketable equity securities still held at the end of the period		$	(71,290)	$	43,801

Investments in Affiliates. As of March 31, 2026, the Company’s healthcare subsidiary held investments in several affiliates that GHG actively manages; GHG held a 40% interest in each of the following affiliates: Residential Home Health Illinois, Residential Hospice Illinois, Mary Free Bed at Home, and Allegheny Health Network Healthcare at Home. For the three months ended March 31, 2026 and 2025, the Company recorded $4.1 million and $3.8 million, respectively, in revenue for services provided to the affiliates of GHG.

As of March 31, 2026, the Company held a 50.4%, 41.4% and 25.2% interest in N2K Networks, Realm and Intersection, respectively, on a fully diluted basis, and accounts for these investments under the equity method. The Company holds two of the five seats of N2K Networks’ governing board with the other shareholders retaining substantive participation rights to control the financial and operating decisions of N2K Networks through representation on the board. In May 2024, the Company entered into a convertible promissory note agreement to loan N2K Networks $2.0 million. The convertible promissory note bears interest at a rate of 12% per annum and, subject to conversion provisions, all unpaid interest and principal are due by May 2027.

The Company had $46.9 million and $30.0 million in its investment account that represents cumulative undistributed income in its investments in affiliates as of March 31, 2026 and December 31, 2025, respectively.

Additionally, Kaplan International Holdings Limited (KIHL) held a 45% interest in a joint venture formed with University of York. KIHL loaned the joint venture £22 million, which is repayable over 25 years at an interest rate of 7% and guaranteed by the University of York. The outstanding balance on this loan was £18.8 million as of March 31, 2026. The loan is repayable by December 2041.

Cost Method Investments. The Company held investments without readily determinable fair values in a number of equity securities that are accounted for as cost method investments, which are recorded at cost, less impairment, and adjusted for observable price changes for identical or similar investments of the same issuer. The carrying value of these investments was $49.4 million as of March 31, 2026 and December 31, 2025, respectively.

4. ACCOUNTS RECEIVABLE, ACCOUNTS PAYABLE, VEHICLE FLOOR PLAN PAYABLE AND ACCRUED LIABILITIES

Accounts receivable consist of the following:


	As of
	March 31, 2026		December 31, 2025
(in thousands)
Receivables from contracts with customers, less estimated credit losses of $24,534 and $23,164	$	461,970	$	519,068
Other receivables	58,512		57,686
	$	520,482	$	576,754

Credit loss expense was $1.5 million and $1.1 million for the three months ended March 31, 2026 and 2025, respectively.

Accounts payable, vehicle floor plan payable and accrued liabilities consist of the following:


	As of
	March 31, 2026		December 31, 2025
(in thousands)
Accounts payable	$	167,742	$	181,009
Vehicle floor plan payable	114,668		118,959
Accrued compensation and related benefits	131,395		194,972
Other accrued liabilities	213,623		226,686
	$	627,428	$	721,626

Cash overdrafts of $0.7 million and $0.6 million are included in accounts payable as of March 31, 2026 and December 31, 2025, respectively.

The Company finances new, used and service loaner vehicle inventory through standardized floor plan facilities with Truist Bank and Toyota Motor Credit Corporation and Ford Motor Credit Company. At March 31, 2026, the floor plan facilities bore interest at variable rates that are based on Secured Overnight Financing Rate (SOFR) and prime-based interest rates. The weighted average interest rate for the floor plan facilities was 5.7% and 6.3% for the three months ended March 31, 2026 and 2025, respectively. The Company incurred floor plan interest expense of $1.7 million and $2.2 million for the three months ended March 31, 2026 and 2025, respectively. Changes in the vehicle floor plan payable are reported as cash flows from financing activities in the Condensed Consolidated Statements of Cash Flows.

The floor plan facilities are collateralized by vehicle inventory and other assets of the relevant dealership subsidiary, and contain a number of covenants, including, among others, covenants restricting the dealership subsidiary with respect to the creation of liens and changes in ownership, officers and key management personnel. The Company was in compliance with all of these restrictive covenants as of March 31, 2026.

The floor plan interest expense related to the vehicle floor plan arrangements is offset by amounts received from manufacturers in the form of floor plan assistance capitalized in inventory and recorded against cost of goods sold in the Condensed Consolidated Statements of Operations when the associated inventory is sold. For the three months ended March 31, 2026 and 2025, the Company recognized a reduction in cost of goods sold of $1.9 million and $2.0 million, respectively, related to manufacturer floor plan assistance.

As of March 31, 2026 and December 31, 2025, the Company had $99.2 million and $105.9 million, respectively, in obligations outstanding related to floor plan facilities associated with new vehicles.

5. INVENTORIES AND CONTRACTS IN PROGRESS

Inventories and contracts in progress consist of the following:


	As of
	March 31, 2026		December 31, 2025
(in thousands)
Raw materials	$	80,855	$	77,977
Work-in-process	13,804		12,906
Finished goods	208,344		209,287
Contracts in progress	3,889		3,200
	$	306,892	$	303,370

6. GOODWILL AND OTHER INTANGIBLE ASSETS

During the first quarter of 2026, in connection with the classification of the KLG disposal group as held for sale, the Company recognized a goodwill impairment charge of $1.0 million at Kaplan International (see Note 2).

Amortization of intangible assets for the three months ended March 31, 2026 and 2025, was $6.1 million and $7.8 million, respectively. Amortization of intangible assets is estimated to be approximately $17 million for the remainder of 2026, $9 million in 2027, $6 million in 2028, $5 million in 2029, $5 million in 2030 and $13 million thereafter.

The changes in the carrying amount of goodwill, by segment, were as follows:


(in thousands)	Education		Television Broadcasting		Healthcare		Manufacturing		Automotive		Other Businesses		Total
As of December 31, 2025
Goodwill	$	1,181,284	$	190,815	$	136,637	$	272,523	$	140,832	$	108,943	$	2,031,034
Accumulated impairment losses	(331,151)		—		—		(82,062)		—		(32,155)		(445,368)
	850,133		190,815		136,637		190,461		140,832		76,788		1,585,666


Acquisition	—		—		17,996		—		—		—		17,996
Impairment	(976)		—		—		—		—		—		(976)


Foreign currency exchange rate changes	(3,197)		—		—		—		—		—		(3,197)
As of March 31, 2026
Goodwill	1,178,087		190,815		154,633		272,523		140,832		108,943		2,045,833
Accumulated impairment losses	(332,127)		—		—		(82,062)		—		(32,155)		(446,344)
	$	845,960	$	190,815	$	154,633	$	190,461	$	140,832	$	76,788	$	1,599,489

The changes in carrying amount of goodwill at the Company’s education and healthcare divisions were as follows:


(in thousands)	Kaplan International		Higher Education		Supplemental Education		Total Education		CSI		Other Healthcare		Total Healthcare
As of December 31, 2025
Goodwill	$	614,096	$	174,564	$	392,624	$	1,181,284	$	87,140	$	49,497	$	136,637
Accumulated impairment losses	—		(111,324)		(219,827)		(331,151)		—		—		—
	614,096		63,240		172,797		850,133		87,140		49,497		136,637


Acquisition	—		—		—		—		—		17,996		17,996
Impairment	(976)		—		—		(976)		—		—		—


Foreign currency exchange rate changes	(3,168)		—		(29)		(3,197)		—		—		—
As of March 31, 2026
Goodwill	610,928		174,564		392,595		1,178,087		87,140		67,493		154,633
Accumulated impairment losses	(976)		(111,324)		(219,827)		(332,127)		—		—		—
	$	609,952	$	63,240	$	172,768	$	845,960	$	87,140	$	67,493	$	154,633

Other intangible assets consist of the following:


		As of March 31, 2026						As of December 31, 2025
(in thousands)	Useful Life Range	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Amortized Intangible Assets
Student and customer relationships	2–10 years	$	296,773	$	259,893	$	36,880	$	307,312	$	266,453	$	40,859
Trade names and trademarks	2–10 years	108,127		93,878		14,249		114,227		98,147		16,080
Network affiliation agreements	10 years	17,400		16,022		1,378		17,400		15,588		1,812
Databases and technology	3–6 years	30,224		28,349		1,875		32,376		30,293		2,083

Other	1–8 years	38,063		37,330		733		38,063		37,266		797
		$	490,587	$	435,472	$	55,115	$	509,378	$	447,747	$	61,631
Indefinite-Lived Intangible Assets
Franchise agreements		$	97,002					$	97,002
Trade names and trademarks		62,169						62,653
FCC licenses		11,000						11,000

Other		150						150
		$	170,321					$	170,805

7. DEBT

The Company’s borrowings consist of the following:


				As of

(in thousands)	Maturities	Stated Interest Rate	Effective Interest Rate	March 31, 2026		December 31, 2025
Unsecured notes (1)	2033	5.625%	5.625%	$	493,550	$	493,625

Revolving credit facility	2030	5.04% - 7.13%	5.13%	149,115		222,466
Real estate term loan (2)	2028	5.42% - 5.45%	5.49%	90,596		91,836
Capital term loan (3)	2028	6.17% - 6.20%	6.24%	62,153		64,079





Other indebtedness	2026 - 2028	6.25% - 8.00%		26,568		8,750
Total Debt				821,982		880,756
Less: current portion				(107,098)		(175,138)
Total Long-Term Debt				$	714,884	$	705,618

___________

(1) The carrying value is net of $6.4 million of unamortized debt issuance costs as of March 31, 2026 and December 31, 2025.

(2) The carrying value is net of $0.1 million of unamortized debt issuance costs as of March 31, 2026 and December 31, 2025.

(3) The carrying value is net of $0.4 million and $0.5 million of unamortized debt issuance costs as of March 31, 2026 and December 31, 2025, respectively.

On November 24, 2025, the Company issued $500 million of 5.625% unsecured eight-year fixed-rate notes due December 1, 2033 (the Notes). Interest is paid semi-annually on June 1 and December 1. Also on November 24,

2025, the Company used the net proceeds from the sale of the notes, together with the borrowings under the revolving credit agreement, to (i) redeem the $400 million of 5.75% unsecured notes due June 1, 2026, (ii) refinance outstanding revolving loans under the existing revolving credit facility, and (iii) repay all amounts outstanding under the Company’s existing $150 million term loan. On October 21, 2025, the automotive subsidiary borrowed $38.7 million under the delayed draw term loan to finance the acquisition of a Honda automotive dealership, including the real property for the dealership operations.

In combination with the issuance of the Notes, the Company amended and restated the Second Amended and Restated Five Year Credit Agreement, dated as of May 3, 2022, to, among other things, (i) increase the Company’s borrowing capacity by replacing the existing revolving commitments with a new revolving credit facility in the aggregate principal amount of $400 million, (ii) extend the maturity of the facility to November 24, 2030, and (iii) increase the letter of credit sublimit to $40 million.

At March 31, 2026 and December 31, 2025, the fair value of the Company’s 5.625% unsecured notes, based on quoted market prices (Level 2 fair value assessment), totaled $489.5 million and $504.0 million, respectively.

The outstanding balance on the Company’s $400 million unsecured revolving credit facility was $149.1 million as of March 31, 2026, consisting of U.S. dollar borrowings of $83.0 million with interest payable at SOFR plus 1.375% or prime rate plus 0.375%, and British Pound borrowings of £50 million with interest payable at Daily Sterling Overnight Index Average (SONIA) plus 1.375%.

The fair value of the Company’s other debt, which is based on Level 2 inputs, approximates its carrying value as of March 31, 2026 and December 31, 2025. The Company is in compliance with all financial covenants of the revolving credit facility and term loans as of March 31, 2026.

During the three months ended March 31, 2026 and 2025, the Company had average borrowings outstanding of approximately $892.8 million and $789.1 million, respectively, at average annual interest rates of approximately 5.7% and 6.0%, respectively. During the three months ended March 31, 2026 and 2025, the Company incurred net interest expense of $13.8 million and $79.8 million, respectively.

During the three months ended March 31, 2026, the Company recorded interest income of $0.7 million to adjust the fair value of the mandatorily redeemable noncontrolling interest. During the three months ended March 31, 2025, the Company recorded interest expense of $66.4 million to adjust the fair value of the mandatorily redeemable noncontrolling interest. The fair value of the mandatorily redeemable noncontrolling interest was based on the fair value of the underlying subsidiaries owned by GHC One and GHC Two, after taking into account any debt and other noncontrolling interests of its subsidiary investments. The fair value of the owned subsidiaries is determined by reference to either a discounted cash flow or EBITDA multiple, which approximates fair value (Level 3 fair value assessment) (See Note 2 and 8).

8. FAIR VALUE MEASUREMENTS

The Company’s financial assets and liabilities measured at fair value on a recurring basis were as follows:


	As of March 31, 2026
(in thousands)	Level 1		Level 2		Level 3		Total
Assets
Money market investments (1)	$	—	$	7,527	$	—	$	7,527
Marketable equity securities (2)	966,719		—		—		966,719
Other current investments (3)	—		5,982		—		5,982

Total Financial Assets	$	966,719	$	13,509	$	—	$	980,228
Liabilities

Contingent consideration liabilities (4)	$	—	$	—	$	1,223	$	1,223
Interest rate swaps (5)	—		1,672		—		1,672
Mandatorily redeemable noncontrolling interest (6)	—		—		7,636		7,636
Total Financial Liabilities	$	—	$	1,672	$	8,859	$	10,531


	As of December 31, 2025
(in thousands)	Level 1		Level 2		Level 3		Total
Assets
Money market investments (1)	$	—	$	5,251	$	—	$	5,251
Marketable equity securities (2)	1,081,938		—		—		1,081,938
Other current investments (3)	—		7,032		—		7,032


Total Financial Assets	$	1,081,938	$	12,283	$	—	$	1,094,221
Liabilities

Contingent consideration liabilities (4)	$	—	$	—	$	1,526	$	1,526
Interest rate swaps (5)	—		2,289		—		2,289

Mandatorily redeemable noncontrolling interest (6)	—		—		8,401		8,401
Total Financial Liabilities	$	—	$	2,289	$	9,927	$	12,216

____________


(1)			The Company’s money market investments are included in cash and cash equivalents and the value considers the liquidity of the counterparty.
(2)			The Company’s investments in marketable equity securities are held in common shares of U.S. corporations that are actively traded on U.S. stock exchanges. Price quotes for these shares are readily available.
(3)			Includes mutual funds, which are valued using a market approach based on the quoted market prices of the security or inputs that include quoted market prices for similar instruments.
(4)			Included in Current liabilities held for sale and Noncurrent liabilities held for sale as of March 31, 2026. The balances were included in Accounts payable, vehicle floor plan payable and accrued liabilities and Other Liabilities as of December 31, 2025. The Company determined the fair value of the contingent consideration liabilities using either a Monte Carlo simulation, Black-Scholes model, or probability-weighted analysis depending on the type of target included in the contingent consideration requirements (revenue, EBITDA, client retention). All analyses included estimated financial projections for the acquired businesses and acquisition-specific discount rates.
(5)			Included in Other Liabilities. The Company utilized a market approach model using the notional amount of the interest rate swaps multiplied by the observable inputs of time to maturity and market interest rates.
(6)			The fair value of the mandatorily redeemable noncontrolling interest is based on the fair value of the underlying subsidiaries owned by GHC One and GHC Two, after taking into account any debt and other noncontrolling interests of its subsidiary investments. The fair value of the owned subsidiaries is determined using enterprise value analyses which include an equal weighing between guideline public company and discounted cash flow analyses.

The following tables provide a reconciliation of changes in the Company’s financial liabilities measured at fair value on a recurring basis, using Level 3 inputs:


(in thousands)	Contingent consideration liabilities		Mandatorily redeemable noncontrolling interest
As of December 31, 2025	$	1,526	$	8,401

Changes in fair value (1)	—		(669)
Capital contributions	—		4
Accretion of value included in net income (1)	21		—
Settlements or distributions	(299)		(100)
Foreign currency exchange rate changes	(25)		—
As of March 31, 2026	$	1,223	$	7,636


(in thousands)	Contingent consideration liabilities		Mandatorily redeemable noncontrolling interest
As of December 31, 2024	$	1,419	$	159,548

Changes in fair value (1)	—		66,407
Capital contributions	—		80
Accretion of value included in net income (1)	46		—
Settlements or distributions	—		(205,315)
Foreign currency exchange rate changes	20		—
As of March 31, 2025	$	1,485	$	20,720

____________


(1)			Changes in fair value and accretion of value of contingent consideration liabilities are included in Selling, general and administrative expenses and the changes in fair value of mandatorily redeemable noncontrolling interest is included in Interest expense in the Company’s Condensed Consolidated Statements of Operations.

Mandatorily Redeemable Noncontrolling Interest. The mandatorily redeemable noncontrolling interest represents the ownership portion of a group of minority shareholders, consisting of a group of current and former senior managers of the healthcare business, in subsidiaries of GHG. The Company established GHC One and GHC Two as vehicles to invest in a portfolio of healthcare businesses together with the group of senior managers of GHG. As the holder of preferred units, the Company is obligated to contribute 95% of the capital required for the acquisition of portfolio investments with the remaining 5% of the capital coming from the group of senior managers. The operating agreements of GHC One and GHC Two require the dissolution of the entities on March 31, 2026, and March 31, 2029, respectively, at which time the net assets will be distributed to its members. As a preferred unit holder, the Company will receive an amount up to its contributed capital plus a preferred annual return of 8% (guaranteed return) after the group of senior managers has received the redemption of their 5% interest in net assets (manager return). All distributions in excess of the manager and guaranteed return will be paid to common unit holders, which currently comprise the group of senior managers of GHG. The Company may convert its preferred units to common units at any time after which it will receive 80% of all distributions in excess of the manager return, with the remaining 20% of excess distributions going to the group of senior managers as holders of the other common units. The mandatorily redeemable noncontrolling interest related to GHC One is reported as a current liability at March 31, 2026 and December 31, 2025 in the Condensed Consolidated Balance Sheets. The mandatorily redeemable noncontrolling interest related to GHC Two is reported as a noncurrent liability at March 31, 2026 and December 31, 2025 in the Condensed Consolidated Balance Sheets.

Other. During the first quarter of 2026, in connection with the classification of the KLG disposal group as held for sale, the Company recognized total impairment charges of $19.0 million, consisting of a $1.0 million goodwill impairment charge and an $18.0 million impairment charge related to the asset group held for sale. The Company used a market approach to estimate the fair value of the KLG disposal group (see Note 2 and 6).

9. REVENUE FROM CONTRACTS WITH CUSTOMERS

The Company generated 78% of its revenue from U.S. domestic sales for each of the three months ended March 31, 2026 and 2025, respectively. The remaining 22% of revenue was generated from non-U.S. sales for the three months ended March 31, 2026 and 2025.

For each of the three months ended March 31, 2026 and 2025, the Company recognized 54% of its revenue over time as control of the services and goods transferred to the customer, and the remaining 46% at a point in time, when the customer obtained control of the promised goods.

Contract Assets. As of March 31, 2026, the Company recognized a contract asset of $28.5 million related to a contract at a Kaplan International business, of which $5.1 million is included in Other current assets and $23.4

million is included in Deferred Charges and Other Assets. The Company expects to recognize an additional $211.7 million related to the remaining performance obligation in the contract over the next three years. As of December 31, 2025, the contract asset was $36.5 million, of which $4.4 million was included in Other current assets and $32.1 million was included in Deferred Charges and Other Assets. Additional contract assets of $2.7 million and $3.0 million are included in Other current assets on the Company’s Condensed Consolidated Balance Sheets as of March 31, 2026 and December 31, 2025, respectively.

Deferred Revenue. The Company records deferred revenue when cash payments are received or due in advance of the Company’s performance which includes some payments that are refundable due to the contractual right of the customer to cancel the agreement. As of March 31, 2026 and December 31, 2025, 15% and 22%, respectively, of the Company’s deferred revenue consisted of prepaid amounts which are refundable. The following table presents the change in the Company’s deferred revenue balance:


	As of
	March 31, 2026		December 31, 2025		%
(in thousands)					Change
Deferred revenue	$	369,183	$	418,090	(12)

The majority of the change in the deferred revenue balance is related to the cyclical nature of services in the Kaplan International division and the reclassification of deferred revenue included in the KLG disposal group (see Note 2), offset by increases in the Supplemental Education division. During the three months ended March 31, 2026, the Company recognized $218.0 million related to the Company’s deferred revenue balance as of December 31, 2025, including $31.2 million of prepaid amounts which were refundable at the prior year-end.

Revenue allocated to remaining performance obligations represents deferred revenue amounts that will be recognized as revenue in future periods. As of March 31, 2026, the deferred revenue balance related to certain medical and nursing qualifications with an original contract length greater than twelve months at Kaplan Supplemental Education was $6.0 million. Kaplan Supplemental Education expects to recognize 56% of this revenue over the next twelve months and the remainder thereafter.

Costs to Obtain a Contract. The following table presents changes in the Company’s costs to obtain a contract asset:


(in thousands)	Balance at Beginning of Period		Costs associated with new contracts		Less: Costs amortized during the period		Other		Balance at End of Period
2026	$	42,404	$	21,832	$	(25,035)	$	(2,627)	$	36,574

The majority of other activity was related to the reclassification of costs to obtain contracts assets included in the KLG disposal group (see Note 2) and currency translation adjustments for the three months ended March 31, 2026.

10. EARNINGS PER SHARE

The Company’s unvested restricted stock awards contain nonforfeitable rights to dividends and, therefore, are considered participating securities for purposes of computing earnings per share pursuant to the two-class method. The diluted earnings per share computed under the two-class method is lower than the diluted earnings per share computed under the treasury stock method, resulting in the presentation of the lower amount in diluted earnings per share. The computation of the earnings per share under the two-class method excludes the income attributable to the unvested restricted stock awards from the numerator and excludes the dilutive impact of those underlying shares from the denominator.

The following reflects the Company’s net income and share data used in the basic and diluted earnings per share computations using the two-class method:


	Three Months Ended March 31
(in thousands, except per share amounts)		2026			2025
Numerator:
Numerator for basic earnings per share:
Net income attributable to Graham Holdings Company common stockholders		$	29,106		$	23,894
Less: Dividends paid-common stock outstanding and unvested restricted shares		(16,398)			(15,662)
Undistributed earnings		12,708			8,232
Percent allocated to common stockholders		99.44		%	99.38		%
		12,636			8,182
Add: Dividends paid-common stock outstanding		16,306			15,563
Numerator for basic earnings per share		$	28,942		$	23,745
Add: Additional undistributed earnings due to dilutive stock options		1			—
Numerator for diluted earnings per share		$	28,943		$	23,745
Denominator:
Denominator for basic earnings per share:
Weighted average shares outstanding		4,331			4,320
Add: Effect of dilutive stock options		44			38
Denominator for diluted earnings per share		4,375			4,358
Graham Holdings Company Common Stockholders:
Basic earnings per share		$	6.68		$	5.50
Diluted earnings per share		$	6.62		$	5.45

____________

Earnings per share amounts may not recalculate due to rounding.

Diluted earnings per share excludes the following weighted average potential common shares, as the effect would be antidilutive, as computed under the treasury stock method:


	Three Months Ended March 31
(in thousands)		2026	2025
Weighted average restricted stock		17	12

The diluted earnings per share amounts for each of the three months ended March 31, 2026 and 2025 excludes the effect of 1,000 contingently issuable shares outstanding as their inclusion would have been antidilutive due to a market condition.

In the three months ended March 31, 2026 and 2025, the Company declared regular dividends totaling $3.76 and $3.60 per common share, respectively.

11. PENSION PLANS

Defined Benefit Plans. The total benefit arising from the Company’s defined benefit pension plans consists of the following components:


	Three Months Ended March 31
(in thousands)		2026		2025
Service cost		$	11,580	$	12,192
Interest cost		8,695		6,421
Expected return on assets		(44,280)		(41,971)
Amortization of prior service credit		(496)		(519)

Net Periodic Benefit		(24,501)		(23,877)


Special separation benefit expense		4,100		624
Total Benefit		$	(20,401)	$	(23,253)

In the first quarter of 2026, the Company recorded $4.1 million in expenses related to Separation Incentive Programs (SIPs) for certain Kaplan, Graham Media Group, Joyce, Dekko, Framebridge, Code3, Slate and Corporate employees. In the first quarter of 2025, the Company recorded $0.6 million in expenses related to a SIP for certain WGB employees. These SIPs were funded from the assets of the Company’s pension plans.

The total cost arising from the Company’s Supplemental Executive Retirement Plan (SERP) consists of the following components:


	Three Months Ended March 31
(in thousands)		2026		2025
Service cost		$	289	$	239
Interest cost		1,155		1,197


Net Periodic Cost		$	1,444	$	1,436

Defined Benefit Plan Assets. The Company’s defined benefit pension obligations are funded by a portfolio made up of private investment funds and a relatively small number of stocks and high-quality fixed-income securities that are held by a third-party trustee. The assets of the Company’s pension plans were allocated as follows:


	As of
	March 31, 2026		December 31, 2025

U.S. equities	63	%	63	%
Private investment funds	18	%	17	%
International equities	15	%	16	%
U.S. fixed income	4	%	4	%

	100	%	100	%

The Company manages approximately 43% of the pension assets internally, of which the majority is invested in Berkshire Hathaway stock, with the remaining investments in private investment funds, Markel stock, and short-term fixed-income securities. The remaining 57% of plan assets are managed by two investment companies. The goal of the investment managers is to produce moderate long-term growth in the value of these assets, while protecting them against large decreases in value. Both investment managers may invest in a combination of equity and fixed-income securities and cash. The managers are not permitted to invest in securities of the Company or in alternative investments. One investment manager cannot invest more than 15% of the assets at the time of purchase in each of the stocks of Alphabet and Berkshire Hathaway, and no more than 50% of the assets it manages in specified international exchanges at the time the investment is made. The other investment manager cannot invest more than 20% of the assets at the time of purchase in the stock of Berkshire Hathaway and no more than 15% of the assets it manages in specified international exchanges at the time the investment is made. Excluding the exceptions noted above, the investment managers cannot invest more than 10% of the assets in the securities of any other single issuer, except for obligations of the U.S. Government, without receiving prior approval from the Plan administrator.

In determining the expected rate of return on plan assets, the Company considers the relative weighting of plan assets, the historical performance of total plan assets and individual asset classes and economic and other indicators of future performance. In addition, the Company may consult with and consider the input of financial and other professionals in developing appropriate return benchmarks.

The Company evaluated its defined benefit pension plan asset portfolio for the existence of significant concentrations (defined as greater than 10% of plan assets) of credit risk as of March 31, 2026. Types of concentrations that were evaluated include, but are not limited to, investment concentrations in a single entity, type of industry, foreign country and individual fund. At March 31, 2026, the pension plan held investments in one common stock and one private investment fund that exceeded 10% of total plan assets, valued at $1,199.5 million, or approximately 38% of total plan assets. At December 31, 2025, the pension plan held investments in one common stock and one private investment fund that exceeded 10% of total plan assets, valued at $1,267.4 million, or approximately 37% of total plan assets. Assets also included $111.0 million and $124.7 million of Markel shares at March 31, 2026 and December 31, 2025, respectively.

12. OTHER NON-OPERATING EXPENSE

A summary of non-operating expense is as follows:


	Three Months Ended March 31
(in thousands)		2026		2025

Foreign currency loss, net		(1,224)		(4,379)

Gain on sale of cost method investment		484		—




Other gain, net		312		314
Total Other Non-Operating Expense		$	(428)	$	(4,065)

13. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

The other comprehensive (loss) income consists of the following components:


	Three Months Ended March 31
	2026						2025
	Before-Tax		Income		After-Tax		Before-Tax		Income		After-Tax
(in thousands)	Amount		Tax		Amount		Amount		Tax		Amount
Foreign currency translation adjustments:


Translation adjustments arising during the period	$	(6,248)	$	—	$	(6,248)	$	14,267	$	—	$	14,267
Pension and other postretirement plans:
Amortization of net prior service credit included in net income	(496)		130		(366)		(519)		133		(386)
Amortization of net actuarial gain included in net income	(258)		67		(191)		(379)		97		(282)


	(754)		197		(557)		(898)		230		(668)
Cash flow hedges:
Gain (loss) for the period	626		(163)		463		(679)		176		(503)
Other Comprehensive (Loss) Income	$	(6,376)	$	34	$	(6,342)	$	12,690	$	406	$	13,096

The accumulated balances related to each component of other comprehensive income (loss) are as follows:


(in thousands, net of taxes)	Cumulative Foreign Currency Translation Adjustment		Unrealized Gain on Pensions and Other Postretirement Plans		Cash Flow Hedges		Accumulated Other Comprehensive Income
As of December 31, 2025	$	(12,262)	$	601,064	$	(1,722)	$	587,080

Other comprehensive (loss) income before reclassifications	(6,248)		—		299		(5,949)
Net amount reclassified from accumulated other comprehensive income (loss)	—		(557)		164		(393)
Net other comprehensive (loss) income	(6,248)		(557)		463		(6,342)
As of March 31, 2026	$	(18,510)	$	600,507	$	(1,259)	$	580,738

The amounts and line items of reclassifications out of Accumulated Other Comprehensive Income (Loss) are as follows:


	Three Months Ended March 31			Affected Line Item in the Condensed Consolidated Statements of Operations

(in thousands)		2026				2025



Pension and Other Postretirement Plans:
Amortization of net prior service credit		$	(496)	$	(519)		(1)
Amortization of net actuarial gain		(258)		(379)			(1)

		(754)		(898)			Before tax
		197		230			Provision for Income Taxes
		(557)		(668)			Net of Tax

Cash Flow Hedges		164		60			Interest expense


Total reclassification for the period		$	(393)	$	(608)		Net of Tax

____________

(1) These accumulated other comprehensive income (loss) components are included in the computation of net periodic pension and postretirement plan cost (see Note 11) and are included in non-operating pension and postretirement benefit income in the Company’s Condensed Consolidated Statements of Operations.

14. CONTINGENCIES

Litigation, Legal and Other Matters. The Company and its subsidiaries are subject to complaints and administrative proceedings and are defendants in various civil lawsuits that have arisen in the ordinary course of their businesses, including contract disputes; actions alleging negligence, libel, defamation and invasion of privacy; trademark, copyright and patent infringement; real estate lease and sublease disputes; violations of employment laws and applicable wage and hour laws; and statutory or common law claims involving current and former students and employees. Although the outcomes of the legal claims and proceedings against the Company cannot be predicted with certainty, based on currently available information, management believes that there are no existing claims or proceedings that are likely to have a material effect on the Company’s business, financial condition, results of operations or cash flows. However, based on currently available information, management believes it is reasonably possible that future losses from existing and threatened legal, regulatory and other proceedings in excess of the amounts recorded could reach approximately $20 million.

15. BUSINESS SEGMENTS

The Company has seven reportable segments: Kaplan International, Kaplan Higher Education, Kaplan Supplemental Education, Television Broadcasting, CSI, Manufacturing and Automotive.

As of March 31, 2026, Kaplan had a total outstanding accounts receivable balance of $72.9 million from Purdue Global related to amounts due for reimbursements for services, fees earned and a deferred fee. Included in this total was a $20.0 million short-term receivable balance related to the advance during the initial KU Transaction.

The Company’s segment information is as follows:


	Three Months Ended March 31, 2026
(in thousands)	Education		Television Broadcasting		Healthcare		Manufacturing		Automotive		Total Segments
Operating Revenues	$	440,479	$	111,553	$	209,340	$	125,034	$	267,624	$	1,154,030
Reconciliation of Revenue
Other Businesses and Corporate Office Revenues (1)											82,599
Intersegment Elimination											(637)
Total Consolidated Revenues											$	1,235,992

Less: Significant Expenses (2)
Cost of Revenue (3)	167,427				133,936		88,214		226,743		616,320
Payroll and Fringe Benefits Expense (4)	117,657		27,285						19,992		164,934
Occupancy Expense	27,377								2,032		29,409
Advertising and Marketing Expense	19,429										19,429
Networking and Programming Expense			30,123								30,123
Management Services (5)									2,292		2,292
Other Segment Items (6)	46,371		15,018		54,082		20,712		9,390		145,573
EBITDAP	$	62,218	$	39,127	$	21,322	$	16,108	$	7,175	$	145,950

Pension Service Cost	4,439		1,488		1,886		1,230		17		9,060
Depreciation Expense	6,054		2,336		1,914		3,135		1,845		15,284

Income from Operations before Amortization of Intangible Assets and Impairment of Goodwill and Asset Group Held for Sale	$	51,725	$	35,303	$	17,522	$	11,743	$	5,313	$	121,606

Other Businesses (7)											(23,600)
Corporate Costs											(15,089)
Amortization of Intangible Assets											(6,055)
Impairment of Goodwill and Asset Group Held for Sale											(19,029)
Income from Operations											$	57,833
Equity in Earnings of Affiliates, Net											34,850
Interest Expense, Net											(13,754)
Non-Operating Pension and Postretirement Benefit Income, Net											31,073
Loss on Marketable Equity Securities, Net											(68,923)
Other Expense, Net											(428)
Income Before Income Taxes											$	40,651

Capital Expenditures	$	4,450	$	2,936	$	2,165	$	1,688	$	6,133	$	17,372
Reconciliation of Capital Expenditures
Other Businesses and Corporate Office Capital Expenditures (8)											3,497
Total Capital Expenditures											$	20,869


(1)	Revenue from segments below the quantitative thresholds is attributable to Other Businesses and the Corporate Office, as described above. None of these operating segments meet the quantitative thresholds for determining reportable segments.
(2)	The significant expense categories and amounts align with the segment-level information that is regularly provided to the chief operating decision maker (CODM).
(3)	Cost of revenue reflects the amounts reported and provided to the CODM and does not necessarily reconcile to the Company's Consolidated Statement of Operations or align across reportable segments. Cost of revenue excludes charges related to depreciation, which is shown separately above.
(4)	Excludes pension service cost, which is shown separately above. Excludes any payroll and related benefits costs captured in cost of revenue.
(5)	Management and operating services provided by Christopher J. Ourisman and his team of industry professionals.
(6)	Other segment items for each reportable segment include:
	(a)	Education (includes Kaplan International, Kaplan Higher Education and Kaplan Supplemental Education) - training and employment expense, travel meals and entertainment expense, operating fees and other general and administrative (G&A) expenses.
	(b)	Television Broadcasting - other broadcast expenses, facilities expenses, third-party commission costs and other selling, general and administrative (SG&A) expenses.
	(c)	Healthcare - indirect costs (e.g. payroll and benefits expenses, general and administrative expenses) and other SG&A expenses.
	(d)	Manufacturing - payroll and fringe benefits expense (SG&A) and other SG&A expenses.
	(e)	Automotive - advertising and marketing expense and other G&A expenses.
(7)	Profit or loss from operating segments below the quantitative thresholds attributable to Other Businesses as described above. These operating segments did not meet any of the quantitative thresholds for determining reportable segments.
(8)	Capital Expenditures from operating segments below the quantitative thresholds are attributable to Other Businesses and the Corporate Office, as described above. None of these operating segments meet the quantitative thresholds for determining reportable segments.

The Company’s education division segment information is as follows:


	Three Months Ended March 31, 2026
(in thousands)	Kaplan International		Higher Education		Supplemental Education		Kaplan Corporate and Other		Intersegment Elimination		Total Education
Operating Revenues	$	271,636	$	92,403	$	76,864	$	271	$	(695)	$	440,479

Less: Significant Expenses (1)
Cost of Revenue (2)	90,001		66,243		11,522				(339)		167,427
Payroll and Fringe Benefits Expense (3)	76,392		3,805		33,032		4,502		(74)		117,657
Occupancy Expense	26,278		158		834		374		(267)		27,377
Advertising and Marketing Expense	8,199		1,920		9,217		93				19,429
Other Segment Items (4)	34,285		401		12,183		(764)		266		46,371
EBITDAP	$	36,481	$	19,876	$	10,076	$	(3,934)	$	(281)	$	62,218

Pension Service Cost	126		1,920		1,986		407				4,439
Depreciation Expense	4,968		267		810		9				6,054

Income (Loss) from Operations before Amortization of Intangible Assets	$	31,387	$	17,689	$	7,280	$	(4,350)	$	(281)	$	51,725

Capital Expenditures	$	3,300	$	815	$	335	$	—			$	4,450


(1)	The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
(2)	Cost of revenue reflects the amounts reported and provided to the CODM and does not necessarily reconcile to the Company's Consolidated Statement of Operations or align across reportable segments. Cost of revenue excludes charges related to depreciation, which is shown separately above.
(3)	Excludes pension service cost, which is shown separately above. Excludes any payroll and related benefits costs captured in cost of revenue.
(4)	Other segment items for each reportable segment include:
	(a)	Kaplan international - travel meals and entertainment expense, training and employment expense, operating fees and other G&A expenses.
	(b)	Higher education - training and employment expense, operating fees and other G&A expenses.
	(c)	Supplemental education - training and employment expense, operating fees and other G&A expenses.

The Company’s healthcare division segment information is as follows:


	Three Months Ended March 31, 2026
(in thousands)	CSI		Other Healthcare		Total Healthcare
Operating Revenues	$	117,781	$	91,559	$	209,340

Less: Significant Expenses (1)
Cost of Revenue (2)	91,144		42,792		133,936
Other Segment Items (3)	20,011		34,071		54,082
EBITDAP	$	6,626	$	14,696	$	21,322

Pension Service Cost	—		1,886		1,886
Depreciation Expense	293		1,621		1,914

Income from Operations before Amortization of Intangible Assets	$	6,333	$	11,189	$	17,522

Capital Expenditures	$	1,567	$	598	$	2,165


(1)			The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
(2)			Cost of revenue reflects the amounts reported and provided to the CODM and does not necessarily reconcile to the Company's Consolidated Statement of Operations. Cost of revenue excludes charges related to depreciation, which is shown separately.
(3)			Other segment items for CSI include indirect costs (e.g. payroll and benefits expenses, general and administrative expenses) and other SG&A expenses.

The Company’s segment information is as follows:


	Three Months Ended March 31, 2025
(in thousands)	Education		Television Broadcasting		Healthcare		Manufacturing		Automotive		Total Segments
Operating Revenues	$	424,731	$	103,554	$	173,741	$	98,005	$	280,991	$	1,081,022
Reconciliation of Revenue
Other Businesses and Corporate Office Revenues (1)											85,517
Intersegment Elimination											(624)
Total Consolidated Revenues											$	1,165,915

Less: Significant Expenses (2)
Cost of Revenue (3)	166,087				100,115		69,737		240,307		576,246
Payroll and Fringe Benefits Expense (4)	113,320		27,764						19,429		160,513
Occupancy Expense	27,922								1,871		29,793
Advertising and Marketing Expense	19,220										19,220
Networking and Programming Expense			31,357								31,357
Management Services (5)									2,052		2,052
Other Segment Items (6)	44,043		14,628		50,406		16,578		9,079		134,734
EBITDAP	$	54,139	$	29,805	$	23,220	$	11,690	$	8,253	$	127,107

Pension Service Cost	4,223		1,419		2,999		1,076		27		9,744
Depreciation Expense	7,764		2,628		1,786		2,703		1,729		16,610

Income from Operations before Amortization of Intangible Assets	$	42,152	$	25,758	$	18,435	$	7,911	$	6,497	$	100,753

Other Businesses (7)											(29,447)
Corporate Costs											(16,009)
Amortization of Intangible Assets											(7,824)

Income from Operations											$	47,473
Equity in Losses of Affiliates, Net											(8,428)
Interest Expense, Net											(79,777)
Non-Operating Pension and Postretirement Benefit Income, Net											34,617
Gain on Marketable Equity Securities, Net											43,801
Other Expense, Net											(4,065)
Income Before Income Taxes											$	33,621

Capital Expenditures	$	4,741	$	198	$	617	$	3,373	$	480	$	9,409
Reconciliation of Capital Expenditures
Other Businesses and Corporate Office Capital Expenditures (8)											4,694
Total Capital Expenditures											$	14,103


(1)	Revenue from segments below the quantitative thresholds is attributable to Other Businesses and the Corporate Office, as described above. None of these operating segments meet the quantitative thresholds for determining reportable segments.
(2)	The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
(3)	Cost of revenue reflects the amounts reported and provided to the CODM and does not necessarily reconcile to the Company's Consolidated Statement of Operations or align across reportable segments. Cost of revenue excludes charges related to depreciation, which is shown separately above.
(4)	Excludes pension service cost, which is shown separately above. Excludes any payroll and related benefits costs captured in cost of revenue.
(5)	Management and operating services provided by Christopher J. Ourisman and his team of industry professionals.
(6)	Other segment items for each reportable segment include:
	(a)	Education (includes Kaplan International, Kaplan Higher Education and Kaplan Supplemental Education) - training and employment expense, travel meals and entertainment expense, operating fees and other G&A expenses.
	(b)	Television Broadcasting - other broadcast expenses, facilities expenses, third-party commission costs and other SG&A expenses.
	(c)	Healthcare - indirect costs (e.g. payroll and benefits expenses, general and administrative expenses) and other SG&A expenses.
	(d)	Manufacturing - payroll and fringe benefits expense (SG&A) and other SG&A expenses.
	(e)	Automotive - advertising and marketing expense and other G&A expenses.
(7)	Profit or loss from operating segments below the quantitative thresholds attributable to Other Businesses as described above. These operating segments did not meet any of the quantitative thresholds for determining reportable segments.
(8)	Capital Expenditures from operating segments below the quantitative thresholds are attributable to Other Businesses and the Corporate Office, as described above. None of these operating segments meet the quantitative thresholds for determining reportable segments.

The Company’s education division segment information is as follows:


	Three Months Ended March 31, 2025
(in thousands)	Kaplan International		Higher Education		Supplemental Education		Kaplan Corporate and Other		Intersegment Elimination		Total Education
Operating Revenues	$	261,256	$	88,487	$	75,403	$	12	$	(427)	$	424,731

Less: Significant Expenses (1)
Cost of Revenue (2)	88,097		66,662		11,755				(427)		166,087
Payroll and Fringe Benefits Expense (3)	70,666		4,477		33,167		5,010				113,320
Occupancy Expense	27,025		176		658		63				27,922
Advertising and Marketing Expense	8,185		1,877		9,030		128				19,220
Other Segment Items (4)	30,532		224		12,185		1,065		37		44,043
EBITDAP	$	36,751	$	15,071	$	8,608	$	(6,254)	$	(37)	$	54,139

Pension Service Cost	140		1,808		1,887		388				4,223
Depreciation Expense	6,549		456		753		6				7,764

Income (Loss) from Operations before Amortization of Intangible Assets	$	30,062	$	12,807	$	5,968	$	(6,648)	$	(37)	$	42,152

Capital Expenditures	$	2,787	$	173	$	1,781	$	—			$	4,741


(1)	The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
(2)	Cost of revenue reflects the amounts reported and provided to the CODM and does not necessarily reconcile to the Company's Consolidated Statement of Operations or align across reportable segments. Cost of revenue excludes charges related to depreciation, which is shown separately above.
(3)	Excludes pension service cost, which is shown separately above. Excludes any payroll and related benefits costs captured in cost of revenue.
(4)	Other segment items for each reportable segment include:
	(a)	Kaplan international - travel meals and entertainment expense, training and employment expense, operating fees and other G&A expenses.
	(b)	Higher education - training and employment expense, operating fees and other G&A expenses.
	(c)	Supplemental education - training and employment expense, operating fees and other G&A expenses.

The Company’s healthcare division segment information is as follows:


	Three Months Ended March 31, 2025
(in thousands)	CSI		Other Healthcare		Total Healthcare
Operating Revenues	$	90,248	$	83,493	$	173,741

Less: Significant Expenses (1)
Cost of Revenue (2)	63,974		36,141		100,115
Other Segment Items (3)	16,422		33,984		50,406
EBITDAP	$	9,852	$	13,368	$	23,220

Pension Service Cost	—		2,999		2,999
Depreciation Expense	176		1,610		1,786

Income from Operations before Amortization of Intangible Assets	$	9,676	$	8,759	$	18,435

Capital Expenditures	$	298	$	319	$	617


(1)			The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
(2)			Cost of revenue reflects the amounts reported and provided to the CODM and does not necessarily reconcile to the Company's Consolidated Statement of Operations. Cost of revenue excludes charges related to depreciation, which is shown separately.
(3)			Other segment items for CSI include indirect costs (e.g. payroll and benefits expenses, general and administrative expenses) and other SG&A expenses.

Asset information for the Company’s business segments is as follows:


	As of
(in thousands)	March 31, 2026		December 31, 2025
Identifiable Assets
Kaplan international	$	1,431,048	$	1,551,682
Higher education	164,418		174,738
Supplemental education	234,128		247,181
Kaplan corporate and other	38,053		34,973
Education	1,867,647		2,008,574
Television broadcasting	388,564		393,097
CSI	197,339		128,170
Other healthcare	183,373		227,457
Healthcare	380,712		355,627
Manufacturing	542,933		535,006
Automotive	579,675		582,715
Total Segments	3,759,531		3,875,019
Other businesses	345,737		357,408
Corporate office	79,149		79,389
Investments in Marketable Equity Securities	966,719		1,081,938
Investments in Affiliates	237,053		229,565
Prepaid Pension Cost	2,792,300		2,772,394

Total Assets	$	8,180,489	$	8,395,713

Item 2. Management’s Discussion and Analysis of Results of Operations and Financial Condition.

This analysis should be read in conjunction with the condensed consolidated financial statements and the notes thereto.

Results of Operations

The Company reported net income attributable to common shares of $29.1 million ($6.62 per share) for the first quarter of 2026, compared to $23.9 million ($5.45 per share) for the first quarter of 2025.

Items included in the Company’s net income for the first quarter of 2026:

•$19.0 million of impairment charges related to the Kaplan Languages Group (KLG) (after-tax impact of $14.3 million, or $3.26 per share);

•$4.1 million in non-operating expenses related to Separation Incentive Programs (SIPs) at the education, television broadcasting and manufacturing divisions, other businesses and the corporate office (after-tax impact of $3.0 million, or $0.69 per share);

•$0.7 million in interest income to adjust the fair value of the mandatorily redeemable noncontrolling interest (after-tax impact of $0.5 million, or $0.12 per share);

•$68.9 million in net losses on marketable equity securities (after-tax impact of $51.3 million, or $11.66 per share);

•$31.0 million in net earnings of affiliates whose operations are not managed by the Company (after-tax impact of $23.1 million, or $5.24 per share); and

•a non-operating gain of $0.5 million from the sale of a cost method investment (after-tax impact of $0.4 million, or $0.08 per share).

Items included in the Company’s net income for the first quarter of 2025:

•$0.6 million in non-operating expenses related to SIPs at other businesses (after-tax impact of $0.5 million, or $0.11 per share);

•$66.4 million in interest expense to adjust the fair value of the mandatorily redeemable noncontrolling interest (after-tax impact of $50.4 million, or $11.49 per share);

•$43.8 million in net gains on marketable equity securities (after-tax impact of $32.6 million, or $7.43 per share); and

•$11.9 million in net losses of affiliates whose operations are not managed by the Company (after-tax impact of $8.9 million, or $2.02 per share).

Revenue for the first quarter of 2026 was $1,236.0 million, up 6% from $1,165.9 million in the first quarter of 2025. Revenues increased at education, television broadcasting, healthcare and manufacturing, partially offset by declines at automotive and other businesses. The Company reported operating income of $57.8 million for the first quarter of 2026, compared to $47.5 million for the first quarter of 2025. The increase in operating results is due to improved results at television broadcasting, manufacturing and other businesses, partially offset by declines at education, healthcare and automotive.

Division Results

Education

Education division revenue totaled $440.5 million for the first quarter of 2026, up 4% from $424.7 million for the same period of 2025. Kaplan reported operating income of $32.4 million for the first quarter of 2026, compared to $40.0 million for the first quarter of 2025.

A summary of Kaplan’s operating results is as follows:


	Three Months Ended
	March 31
(in thousands)		2026		2025		% Change
Revenue
Kaplan international		$	271,636	$	261,256	4
Higher education		92,403		88,487		4
Supplemental education		76,864		75,403		2
Kaplan corporate and other		271		12		—
Intersegment elimination		(695)		(427)		—
		$	440,479	$	424,731	4
Operating Income (Loss)
Kaplan international		$	31,387	$	30,062	4
Higher education		17,689		12,807		38
Supplemental education		7,280		5,968		22
Kaplan corporate and other		(4,350)		(6,648)		35
Amortization of intangible assets		(314)		(2,119)		85
Impairment of goodwill and asset group held for sale		(19,029)		—		—
Intersegment elimination		(281)		(37)		—
		$	32,382	$	40,033	(19)

In the first quarter of 2026, the Company entered into an agreement to sell KLG included in Kaplan International, with an expected closing date of May 1, 2026. At March 31, 2026, the Company classified the assets and liabilities of KLG as held for sale; the Company also recorded a $19.0 million pre-tax impairment charge in the first quarter of 2026 related to the KLG business. Excluding the impairment charge, Kaplan’s operating income was up significantly in the first quarter of 2026.

Kaplan International includes postsecondary education, professional training and language training businesses largely outside the United States (U.S.). Kaplan International revenue increased 4% for the first quarter of 2026 (3% decrease on a constant currency basis) due to increases at Singapore, UK Professional and Kaplan Open Learning (KOL), partially offset by declines at Pathways. Kaplan International reported operating income of $31.4 million in the first quarter of 2026, compared to $30.1 million in the first quarter of 2025. Operating results at Singapore and KOL grew significantly as a result of strong enrollment growth. The increase was partially offset by declines at the Pathways business. In particular, revenues and operating results were down significantly at US Pathways due to the continued adverse impact of changes in U.S. visa policies and practices for international students recruited by Kaplan to study in the U.S.

Higher Education includes the results of Kaplan as a service provider to higher education institutions. Higher Education revenue increased 4% for the first quarter of 2026, due primarily to an increase in the Purdue Global fee recorded. Enrollments at Purdue Global, the largest institutional client, increased 8% for the first three months of 2026 compared to the first three months of 2025. For the first quarter of 2026, Kaplan recorded the full fee from Purdue Global, while only a portion of the fee from Purdue Global was recorded for the first quarter of 2025. However, in the second quarter and first six months of 2025, Kaplan recorded the full fee from Purdue Global. The Company will continue to assess the fee it records from Purdue Global on a quarterly basis to make a determination as to whether to record all or part of the fee in the future and whether to adjust fee amounts recognized in earlier periods. Higher Education operating results improved in the first quarter of 2026 due to an increase in the Purdue Global fee recorded, and a decline in higher education development costs.

Supplemental Education includes Kaplan’s standardized test preparation programs and domestic professional and other continuing education businesses. Supplemental Ed revenue increased 2% due to growth in most of its professional preparation program offerings, offset in part by softness in publishing sales volume. Operating results increased in the first quarter of 2026 from revenue growth and improved margins.

Kaplan corporate and other represents unallocated expenses of Kaplan’s corporate office, other minor businesses and certain shared activities.

In the first quarter of 2026, the Company offered a SIP to certain employees at Kaplan International, Higher Education and Supplemental Education; $1.9 million in related non-operating pension expense was recorded in the first quarter of 2026. This program was funded from the assets of the Company’s pension plan.

Television Broadcasting

A summary of television broadcasting’s operating results is as follows:


	Three Months Ended
	March 31
(in thousands)		2026		2025		% Change
Revenue		$	111,553	$	103,554	8
Operating Income		33,943		24,398		39

Graham Media Group owns seven television stations located in Houston, TX; Detroit, MI; Orlando, FL; San Antonio, TX; Jacksonville, FL; and Roanoke, VA, as well as SocialNewsDesk, a provider of social media management tools designed to connect newsrooms with their users.

Revenue at the television broadcasting division increased 8% to $111.6 million in the first quarter of 2026, from $103.6 million in the same period of 2025. The revenue increase is due to a $7.3 million increase in political advertising revenue and increases from winter Olympics and Super Bowl advertising revenue at the Company’s NBC affiliates in the first quarter of 2026, partially offset by a $2.9 million decrease in retransmission revenue. Operating income for the first quarter of 2026 was up 39% to $33.9 million, from $24.4 million in the same period of 2025, due to higher revenues and lower overall costs.

While per subscriber rates from cable, satellite and OTT providers have grown, overall cable and satellite subscribers are down due to cord cutting, resulting in retransmission revenue net of network fees in 2026 expected to decline compared with 2025, and this trend is expected to continue.

In the first quarter of 2026, the Company offered a SIP to certain employees at the television broadcasting division; $0.6 million in related non-operating pension expense was recorded. This program was funded from the assets of the Company’s pension plan.

In March 2026, the Company’s television station in San Antonio (KSAT) entered into a new network affiliation agreement with ABC that covers the period April 1, 2026 through March 31, 2030.

Healthcare

Healthcare division revenue totaled $209.3 million for the first quarter of 2026, up 20% from $173.7 million for the same period of 2025. Healthcare reported operating income of $17.4 million for the first quarter of 2026, compared to $18.3 million for the first quarter of 2025.

A summary of healthcare division’s operating results is as follows:



	Three Months Ended
	March 31
(in thousands)		2026		2025		% Change
Revenue
CSI		$	117,781	$	90,248	31
Other Healthcare		91,559		83,493		10
		$	209,340	$	173,741	20
Operating Income
CSI		$	6,312	$	9,643	(35)
Other Healthcare		11,114		8,674		28
		$	17,426	$	18,317	(5)

The healthcare group provides nursing care and prescription services for patients receiving in-home infusion treatments through its 93.4% interest in CSI Pharmacy Holding Company, LLC (CSI). In August 2025, CSI purchased Pine Drug Holdings, LLC and was issued a California pharmacy license, with dispensing operations commencing late in the fourth quarter of 2025. CSI revenue increased 31% in the first quarter of 2026 from continued expansion of treatment offerings and patient service areas. Operating results were down in the first quarter of 2026 due to various operational investments including expanding CSI’s pharmacy facility locations; lower operating margins for certain products compared with the first quarter of 2025; and increased incentive compensation expense. The Company expects revenue and operating income growth at CSI for the remainder of 2026 compared with 2025.

Healthcare also includes Graham Healthcare Group (GHG), which provides home health and hospice services in seven states. In March 2026, GHG acquired Covenant Home Health of Havertown, PA, a home health provider in Eastern Pennsylvania. Healthcare also includes Clarus (provides call management SaaS-based solution for physician groups and hospitals), Impact Medical (an allergy, asthma and immunology physician practice), Skin

Clique (a concierge provider of aesthetics products and services) and Surpass Behavioral Health (provides therapy for autism patients). Revenue increased in other healthcare businesses by 10% in the first quarter of 2026 from growth in home health and hospice services and each of the other healthcare businesses. Operating results improved at home health and hospice in the first quarter of 2026, partly due to a reduction in pension expense. Overall, operating results also improved at the other four healthcare businesses in the first quarter of 2026.

The Company also holds interests in four home health and hospice joint ventures managed by GHG, whose results are included in equity in earnings of affiliates in the Company’s Condensed Consolidated Statements of Operations. The Company recorded equity in earnings of $3.5 million and $3.2 million for the first quarters of 2026 and 2025, respectively, from these joint ventures.

Manufacturing

A summary of manufacturing’s operating results is as follows:


	Three Months Ended
	March 31
(in thousands)		2026		2025		% Change
Revenue		$	125,034	$	98,005	28
Operating Income		8,000		5,480		46

Manufacturing includes four businesses: Hoover, a supplier of pressure impregnated kiln-dried lumber and plywood products for fire retardant and preservative applications, and aluminum cladding products for the non-residential market; Dekko, a manufacturer of electrical workspace solutions, architectural lighting and electrical components and assemblies; Joyce, a manufacturer of screw jacks and other linear motion systems; and Forney, a global supplier of products and systems that control and monitor combustion processes in electric utility and industrial applications. On July 15, 2025, Hoover acquired Arconic Architectural Products, LLC, a wholly-owned subsidiary of Arconic Corporation (operating as Hoover Architectural Solutions), which manufactures aluminum cladding products and operates within the broader non-residential materials space from its facility in Eastman, GA. A significant portion of the purchase price was funded by the Company’s assumption of $107.5 million in net pension obligations.

Manufacturing revenues increased 28% in the first quarter of 2026 due to increased revenues at Hoover and Joyce, partially offset by lower revenues at Dekko and Forney. The revenue increase at Hoover is due largely to the Hoover Architectural Solutions business acquisition. Excluding the acquisition, overall volumes were flat in the first quarter of 2026. Hoover results included wood gains on inventory sales in both the first quarter of 2026 and 2025. Manufacturing operating results improved in the first quarter of 2026 due to significant growth at Joyce, and growth at Dekko and Forney. The increase was partially offset by an overall decline at Hoover, due to increased intangible asset amortization and transition costs related to the Arconic acquisition.

In the first quarter of 2026, the Company offered a SIP to certain employees at Dekko and Joyce; $0.2 million in related non-operating pension expense was recorded. This program was funded from the assets of the Company’s pension plan.

Automotive

A summary of automotive’s operating results is as follows:


	Three Months Ended
	March 31
(in thousands)		2026		2025		% Change
Revenue		$	267,624	$	280,991	(5)
Operating Income		5,308		6,492		(18)

Automotive includes eight automotive dealerships in the Washington, DC metropolitan area and Richmond, VA: Ourisman Lexus of Rockville, Ourisman Honda of Tysons Corner, Ourisman Ford of Manassas, Toyota of Woodbridge, Ourisman Chrysler-Dodge-Jeep-Ram of Woodbridge, Ourisman Toyota of Richmond, and Ourisman Kia of Bethesda. In addition, on October 21, 2025, the Company acquired a Honda automotive dealership in Woodbridge, VA, including the real property for the dealership operations. Automotive also includes Roda, which provides valet automotive repair services in the Washington, DC metropolitan area. Christopher J. Ourisman, a member of the Ourisman Automotive Group family of dealerships, and his team of industry professionals operate and manage the dealerships; the Company holds a 90% stake.

The Company ceased operations of the Ourisman Jeep of Bethesda dealership, which was closed in early September 2025.

Revenues for the first quarter of 2026 decreased 5% due partly to the closure of the Ourisman Jeep of Bethesda dealership in September 2025, offset by increased revenues from the Honda of Woodbridge dealership acquisition. Excluding these dealerships, revenues were down mostly from declines in new and used vehicle sales, partially offset by sales growth for services and parts. Operating results were down in the first quarter of 2026 due largely to lower overall sales and gross margins on new and used vehicles, partially offset by earnings from the Honda of Woodbridge dealership acquisition and higher overall gross profit on services and parts.

Other Businesses

A summary of revenue by category for other businesses:


	Three Months Ended
	March 31			%
		2026		2025		Change
Operating Revenues
Specialty (1)		$	39,078	$	38,763	1
Retail (2)		27,097		26,122		4
Media (3)		15,752		20,012		(21)
		$	81,927	$	84,897	(3)

____________


(1)			Includes Clyde’s Restaurant Group (CRG), Decile and Supporting Cast
(2)			Includes Framebridge, Saatchi Art and Society6
(3)			Includes Slate, Foreign Policy, Code3, World of Good Brands (WGB) (sold in 2025) and City Cast

Overall, revenue from other businesses declined 3% in t

Graham Holdings Co 10-Q